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ABSTRACT 
Immigrant studies may help further our understanding of the aetiology of cervical cancer and 
improve its prevention. The overall aim of this thesis is to study the risk of cervical cancer among 
immigrant women in Sweden, their cervical screening attendance and their prognosis after cervical 
cancer diagnosis. Quantitative cohort study designs using data from population-based registers 
were carried out and analysed using Poisson regression and Cox proportional hazard models. A 
quantitative explorative design was used to analyse the results of focus group discussions (FGDs) 
according to the principles of content analysis. 
Compared to Swedish-born women, immigrant women in Sweden had a higher relative risk of 
invasive cervical cancer, particularly women from Denmark, Norway and Central America; the 
opposite was true for immigrant women from Eastern Africa and South Central Asia. Moreover, 
age at immigration and follow-up time were important effect modifiers for the risk of cervical 
cancer among immigrant women (Study I). Average cervical screening attendance was 62% and 
49% among Swedish-born and immigrant women, respectively, and was lowest among women 
who immigrated at older ages. Adherence to recommended screening intervals is very effective 
in preventing cervical cancer (Study II). The qualitative study using FGDs revealed a complex 
rationale for postponing cervical screening that included aspects related to immigration itself, 
including competing needs, organisational and structural factors, and differences in mentality 
(Study III). Non-Nordic immigrant women had a slightly lower risk of dying from cervical cancer 
than Swedish-born women. Both Swedish-born and immigrant women with symptomatic cervical 
cancer showed a 3 to 4-fold excess mortality compared to screening-detected cases. Both 
immigrant and Swedish-born women with low socioeconomic status had an excess risk of dying 
from cervical cancer (Study IV). 
In conclusion, these results suggest a need for targeted prevention both among Swedish-born and 
immigrant women with low socioeconomic status and immigrant women at high-risk for cervical 
cancer, particularly those from Denmark, Norway and Central America, and specifically women 
who immigrate at older ages, during the first 10 years after their arrival. The results on cervical 
cancer prognosis indicate that there is equal access to health care in Sweden, irrespective of 
country of birth. The rationale of immigrant women in FGDs to postpone cervical screening 
reveals an opportunity to motivate these women to attend.  
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Foreword 
Something I cherish is the belief that knowledge and education comprise some of the best tools 
possible to help us manage our lives. My father, Abdellah Azerkan, always talked about the 
importance of studying and acquiring new knowledge during my childhood. He used to say, 
“Strive for knowledge, not for money”. Both of my parents immigrated to Sweden from Morocco 
for work reasons, my father in the 1960s and my mother in the 1970s.  
 
My interest in research began when I was in high school, where I studied in the science 
programme for 3 years. After finalising my nursing and midwifery studies, I worked in various 
maternity wards, but it was during my years at Danderyd Hospital that I became very interested in 
how women give birth in low-income countries. So I approached a midwife colleague of mine that 
was also a PhD student, Marianne Velandia, with my questions about how to further my research 
ideas. Marianne recommended a researcher named Elisabeth Faxelid, who later became my co-
supervisor. I contacted Elisabeth concerning my interest in the home-based delivery care system in 
a rural province called Chefchaouen in the Northern part of Morocco. Elisabeth accepted to be my 
formal supervisor and I applied for and was awarded funding from the Swedish International 
Development Cooperation Agency. I decided that this would be my pilot study, and that its 
outcome would determine whether or not I would pursue a PhD. It was a fantastic and very 
interesting time and a great learning experience. Unfortunately, my father, who accompanied me 
to the study site, had a stroke after 2 months of data collection. We were in the mountains very far 
from a hospital, and when we finally reached adequate health care facilities, it was too late; the 
damage caused by the stroke was permanent and his personality was never the same. This 
experience was so bittersweet that I decided not to continue with research. After some time, 
Elisabeth approached me asking if I would be interested in working in the epidemiology unit of the 
Swedish Institute for Communicable Disease Control (in Swedish: Smittskyddsinstitutet) on a 
project concerning the evaluation of Swedish patients who contracted gonorrhoea and/or 
chlamydia in Thailand, and later had been tested for HIV in Sweden. This was the first time that I 
worked in the field of epidemiology, and I found it very interesting. I met Dr Johan Giesecke, the 
chief of the epidemiology unit, who inspired me to continue in the field of research. I decided that 
my father’s fate should not be in vain and that I would strive for a PhD, the highest degree in 
academia. My parents, who were illiterate when they came to Sweden as immigrants, were given 
great opportunities to learn both Swedish and Arabic, which says something about what a great 
country Sweden is. The combination of subjects: immigrant status, cervical cancer and research, 
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was very interesting to me, and it was with gratitude that I learned of my acceptance to the PhD 
programme, with financial support from the Health Care Sciences Postgraduate School at 
Karolinska Institutet and the Swedish Research Council…and I never looked back.  
 
This thesis is dedicated to my father Abdellah and my mother Aicha. 
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1 INTRODUCTION 
Studies of disease in immigrant populations offer insights into the relative importance of 
environmental factors versus inherited predispositions in cancer aetiology by comparing 
disease risk in immigrant populations living in different physical and social environments (1). 
Cervical cancer is highly associated with persistent infection with sexually transmitted human 
papillomavirus (HPV), which is a necessary cause of invasive cervical cancer (2-4). Due to 
the great variation in the proportion of women infected with HPV, and the distribution of HPV 
types across populations (5), studies on immigrant populations may help identify risk factors, 
and identify which groups of immigrants constitute high-risk groups in different societies. 
This knowledge is essential for any cervical cancer prevention programme (6). About 530 000 
new cases of cervical cancer are estimated to occur annually worldwide, making it the third 
most common cancer among women. Cervical cancer is also the fourth most common cause of 
cancer death among women worldwide, responsible for 275 000 deaths in 2008, of which 
about 88% occurred in middle-to-low-income countries. 
 
On a global scale, cervical cancer is still considered a serious public health burden. Global 
cancer statistics show a clear and striking variation in the incidence of cervical cancer by 
geographical region. High-risk regions include Eastern and Western Africa, Southern Africa, 
Middle Africa, South Central Asia, and South America. Middle- and low-income countries 
carry more than 85% of the global burden of cervical cancer (7). The differences in the 
incidence of cervical cancer by geographical region are mainly due to the establishment of 
screening programmes in high-income countries. Some differences reflect changing data 
sources and improved quality of cancer registers (8). The main determinants of the risk of 
cervical cancer are HPV infection and lack of effective cervical screening. Apart from 
cervical screening, the effect of external factors are minor compared with the extremely high 
primary risk conferred by infection with the most carcinogenic HPV types (9). 
 
Most immigrants have a lower risk of cervical cancer and of mortality from cervical cancer in 
their host country than in their countries of birth (10). Factors associated with persistent HPV 
infection are HPV type, sexual behaviour, age, HIV infection and history of Chlamydia 
trachomatis infection. Furthermore, several studies have found that smoking, multiparity, use 
of oral contraceptives and genetic susceptibility increase the risk of dysplasia and cervical 
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cancer. As for prognosis, immigrant status has been shown as a risk factor for cervical cancer 
diagnosis at a more advanced stage (11-17). 
 
In 2006, it was estimated that around 95 million women, 1.5% of the world’s population, lived 
outside their country of birth. The magnitude and complexity of this international phenomenon 
make immigration an important force in a country’s development and a high-priority issue for 
high-, middle-, and low-income countries. Most immigrant women are of reproductive age, 
which adds to the importance of the role of immigrants in a society (18).  
 
At present, Sweden has a total population of about 4.8 million women, 15% of whom are 
immigrants (19). Immigrants are a heterogeneous group of people, with different cancer risks 
(20). Research on immigrant women diagnosed with cervical cancer in countries with high-
quality universal health care is scarce. Theoretically, in these countries a standardised quality of 
care is offered to all legal residents. This thesis consists both of register-based cohort studies and a 
study based on focus group discussions (FGDs), and explores the risk of cervical cancer among 
immigrant women in Sweden, their cervical screening attendance and their prognosis after 
being diagnosed with cervical cancer. Additionally, the effect of follow-up time and age at 
immigration on cervical cancer has been assessed. 
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2 BACKGROUND 
2.1 CERVICAL CANCER 
Invasive cervical cancer is a malignancy that occurs in the epithelium of the cervix. There are 
three recognised general histological categories of cervical cancer: squamous, glandular, and 
other (21). Squamous cell carcinomas account for about 80% of cervical cancers followed by 
adenocarcinomas. Infection with high-risk HPV types is the necessary cause of both 
squamous and glandular cervical cancer (2-4). It has been estimated that HPV is also 
associated with 90% of anal cancers, and a little less than 50% of other cancers, such as 
oropharyngeal, penile, vaginal and vulvar cancers (22). 
 
Cervical cancer usually arises from the cervical transformation zone. Persistent HPV infection 
can cause changes in cervical cells; these changes are also known as the precancerous lesion 
cervical intraepithelial neoplasia (CIN) (9). The transformation zone is an area of the cervix 
that is uniquely susceptible to HPV-induced neoplastic transformation (21). Both squamous 
cell carcinoma and adenocarcinoma are preceded by distinctive precursor lesions (23). The 
dynamic character of the transformation zone is an important feature in its susceptibility to 
cancer. Indeed, although infection with carcinogenic HPV types is equally common in 
cervical and vaginal specimens (24), cervical cancer is the third most common cancer in 
women worldwide, whereas vaginal cancer is exceedingly rare (25). 
 
 From HPV transmission to invasive cervical cancer 2.1.1
Human papillomavirus types 
Over 100 HPV types have been identified, about 40 of which are known to infect the genital 
tract (26). Genital HPV types have been categorised into low-risk and high-risk types. The 
low-risk types confer only a negligible risk of cancer, two of which are mainly found in 
genital warts (HPV6 and 11 responsible for 90% of genital warts) (27). High-risk HPV types, 
on the other hand, are frequently associated with invasive cervical cancer. The two most 
carcinogenic HPV types are HPV16 and 18, which are responsible for 70% of cervical cancer 
and about 50% of CIN3 (28). As such they are primary targets for HPV vaccines (29). 
 
Human papillomavirus infection 
HPV is the world’s most common sexually transmitted infection (STI). Genital HPV types are 
transmitted through skin-to-skin contact during sexual activity and can apparently ascend to 
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the cervix following infection at the introitus (30). Other HPV transmission routes include 
vertical transmission from mother to infant, the risk of which is greater after vaginal than 
caesarean birth (31). Cervical carcinogenesis is a multistep process that begins with HPV 
infection, and then moves to viral persistence, progression of a clone of persistently infected 
cells to a precancerous lesion, and finally invasion, which can be reproducibly distinguished. 
The spontaneous clearance of HPV infection is common. Regression of precancerous lesions 
to normality does also occur, though it is less frequent (9).  
 
It is likely that most women worldwide have been infected with at least one, if not several 
HPV types during their sexual life (32). Consistent condom use among partners of newly 
sexually active women, suggest that condoms do not eliminate the risk of male-to-female 
genital HPV transmission, though they may reduce it (33). A preliminary association between 
condom use and decreased persistence or progression of HPV infection has been observed in 
a few studies (34;35). 
 
Age at first sexual intercourse can be viewed as a proxy for age at first HPV infection, and 
therefore as a very important variable in cervical cancer development. There is a large peak of 
cervical HPV infections immediately following first sexual intercourse. As the average age at 
first sexual intercourse varies by culture, this also affects the average age at which women 
reach subsequent stages in the carcinogenic process (9). Most HPV infections clear 
spontaneously within 2 years without ever causing precancerous lesions, whereas the 10% of 
infections that persist for 2 years or more are highly linked to the development of precancerous 
lesions. Precancerous lesions are usually detected around 25-30 years of age in regions with 
cervical screening, or about 10 years after first sexual intercourse (9). 
 
From precancerous lesions to cervical cancer 
There are different grades of severity of precancerous lesions, which are often asymptomatic 
and discovered only by cytological examination of a Papanicolaou smear (Pap smear) (36). 
CIN2 is a moderate form of precancerous lesion; CIN3 includes both severe dysplasia and 
carcinoma in situ (meaning that upon histological examination the cancer has not broken through 
the basal epithelium) prior to invasive cervical cancer. CIN2 can be caused by non-
carcinogenic HPV types rarely found in cancer and has substantial regression potential, but it 
is treated in most regions to provide a safety margin against cancer risk (37).  
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The majority of women infected with HPV will clear the infection spontaneously, in the same 
fashion that most precancerous lesions will regress. If effective treatment is not available or 
administered, precancerous lesions that are not detected by screening or do not regress on their 
own will not only progress to invasive cancer, but can expand to blood and lymphatic vessels 
and become metastatic (38). Crude estimates from early studies have suggested a 20-30% risk 
of progression from precancerous lesions to cervical cancer over a 5-10-year time frame (39). 
Apart from age and HPV type, the risk factors for invasion are unknown, but HPV16, 18, and 
45 are found in a higher fraction of cancers than precancerous lesions compared to other HPV 
types (28). 
 
 Worldwide distribution of human papillomavirus types  2.1.2
Globally, cervical cancer accounted for 9% of new cancer cases and 8% of cancer deaths 
among women in 2008. The prevalence of cervical HPV infection is closely related to the 
corresponding risk of cervical cancer in a given country (40-52), and HPV prevalence varies 
greatly across populations (5). Globally, it has been estimated that around 10% of women 
with normal cytology are infected with HPV. However, a broad range of estimates (6.1-
35.5%) have been documented, depending on the HPV testing method, study size, age 
groups, and geographical regions studied (53). One meta-analysis comprising data from more 
than 1 million women in 59 countries showed that the prevalence of genital HPV infection 
among women with normal cytology ranges from 1.6% to 41.9% (54). The estimate varies by 
geographical region and age. African and Latin American regions showed higher average 
HPV prevalence than European, Northern American, and Asian regions. 
 
A pooled analysis of the International Agency for Research on Cancer HPV Prevalence 
Surveys reported regional variation in HPV type distribution among women without 
cytological abnormalities, and showed a nearly 20-fold variation in overall HPV prevalence 
across different geographical regions. The highest overall HPV prevalence was observed in 
sub-Saharan Africa, and the lowest was in Europe, but the variation in HPV prevalence across 
geographical regions was smaller for HPV16 than for other high-risk and low-risk HPV types. 
HPV prevalence was approximately five times higher in sub-Saharan Africa than in Europe, 
with intermediate prevalence in South America and Asia. In all regions HPV16 was twice as 
frequent as any other high-risk type, except in sub-Saharan Africa, where HPV35 was equally 
common. HPV-positive women from Europe and South America were significantly more likely 
to be infected with HPV16 than were women in sub-Saharan Africa, although overall HPV 
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prevalence in sub-Saharan Africa was higher. The proportion of HPV-positive women infected 
with HPV18 was similar across regions, with some heterogeneity in South America and 
Europe. HPV35, 45, 52, 56 and 58 were all more common in HPV-positive women in sub-
Saharan Africa than those in Europe (5). 
 
The complex geographical and biological interplay between different HPV types and host 
immunogenetic factors (e.g., human leukocyte antigen polymorphisms) could be related to 
differences in type-specific HPV prevalence (55). For example, HPV16, which is considered to 
be the most carcinogenic HPV type, seems to be less influenced by immune status than other 
HPV types (56). This finding, coupled with impairment of cellular immunity (e.g., due to 
chronic cervical inflammation, parasitic infection, malnutrition, and, more recently, HIV), may 
contribute to a higher penetrance of HPV types other than HPV16 (5). 
 
 Cervical cancer: aetiology and risk factors 2.1.3
HPV infection and lack of effective screening are major components in the risk of cervical 
cancer. With the exception of cervical screening, external factors have a small impact on the 
risk of cervical cancer compared to the extremely high primary risks conferred by infection 
with the most carcinogenic HPV types (9). Most HPV infections are transient, and the 
proportion of women with persistent HPV infection that eventually develop cervical cancer is 
rather small. Therefore there may be other factors that increase the risk of developing cervical 
cancer. HPV infection is associated with sexual behaviour. Although cervical cancer affects 
many women later in life, sexual behaviour early in life is thought to play a significant role in 
cervical cancer development (57). 
 
Early age at first sexual intercourse (21,58) and a high lifetime number of sexual partners for 
a woman or her partners are considered risk factors for cervical cancer (21). First infection 
with HPV often occurs soon after first sexual intercourse (59), making early age at first 
intercourse a reasonable proxy for early age at first exposure to HPV (60). 
 
One of the explanations for the association between early age at first sexual intercourse and 
risk of cervical cancer is that it may affect the cervix at a time when it is still developing. 
Exposure to carcinogens such as HPV shortly after menarche has been reported to be a likely 
factor in the development of invasive cervical cancer later in life (61). Another explanation 
for this association may be that it is correlated with other high-risk behaviour later in life, for 
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example a lower tendency to practice safe sex (62). The International Collaboration of 
Epidemiological Studies of Cervical Cancer collected data on sexual behaviour from 21 
national or international epidemiological studies and found a gradually increasing risk with 
earlier age at first sexual intercourse (≤14 years of age versus ≥25 years of age), controlling 
for lifetime number of sexual partners, parity and age at first full-term pregnancy (63). 
 
Male circumcision has been shown to decrease the risk of HPV infection and cervical cancer 
in the female partner. This effect was strongest in women whose male partners engaged in 
sexual practices known to increase the risk of exposure to HPV, for example having sexual 
intercourse before 17 years of age, having had six or more sexual partners in one’s lifetime, 
and having a history of contact with sex workers (64). 
 
Other risk factors for cervical cancer have also been considered, such as smoking (65), having 
more than five full-term pregnancies, and use of oral contraceptives for 5 years or more (66). 
The reported 2.5 to 4-fold increase in risk for these co-factors are in general highly 
consistent. The presence of antibodies against Chlamydia trachomatis or herpes simplex virus 
type 2 also modifies the risk of progression to cervical cancer (21,21). HPV-positive women 
with low socioeconomic status might be at higher risk for precancerous lesions (67). With 
regard to nutritional co-factors, there are some indications of a possible protective association 
between higher folate and the risk of precancerous lesions (68). Furthermore, vitamin A 
deficiency is known to be associated with carcinogenesis in humans (69). Findings from a 
meta-analysis indicated that vitamin A intake and blood vitamin A levels can decrease the risk 
of cervical cancer. However, these findings need to be confirmed in large randomised clinical 
trials of vitamin A supplementation (70). 
 
 Immigrant registration in Sweden 2.1.4
Immigration is a major component of population change in Sweden (71). To be registered as an 
immigrant, the person immigrating must intend to stay in Sweden for at least 1 year. Likewise, 
to register as an emigrant the person emigrating must intend to reside abroad for at least 1 year. 
Immigrants from outside the Nordic countries must obtain a residence permit to be registered as 
immigrants. The time of immigration is defined as the actual day of immigration if it is reported 
to the Population Register within 1 week of immigration. However, if the immigration is 
reported after 1 week, it is registered to have taken place the day it is reported.  
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In the Population Register each immigrant is assigned a Personal Identity Number (PIN) by 
which they can be identified. Information from the Swedish Migration Board on people who 
have been granted residence permits in Sweden is shared annually with Statistics Sweden. The 
information includes the reason for immigration and the date of immigration (72). 
 
A residence permit is generally given if asylum is granted. A residence permit gives the right to 
live and work in Sweden. Anyone with a permanent residence permit can also be entered in the 
Population Register, which is managed by the Tax Agency. Those included in this register are 
then included in the Swedish Total Population Register (TPR), managed by Statistics Sweden. 
It is not until the person is registered in the TPR that they are considered “immigrated” in 
national statistics. Some of the most used register variables for immigrants are PIN, place of 
residence, sex, age, citizenship, country of birth, and year of immigration (72).  
 
 Human genetic variation, race and ethnicity 2.1.5
The patterns of human genetic variation show that 5-15% of genetic variation occurs between 
large groups living on different continents, with the remaining majority of the variation 
occurring within these groups (73,74). Therefore, the rationale of using race to distinguish 
these genetically different population groups has been widely questioned (75-78). Moreover, 
a person’s self-ascribed race can differ from assigned race (79). The problems surrounding the 
word “race” became increasingly apparent during the 20th century, so researchers began to 
employ the term “ethnicity” (80). 
 
Ethnicity typically emphasises the cultural, socioeconomic, religious, and political qualities of a 
population rather than their genetic ancestry. It can comprise language, diet, religion, dress, 
customs, kinship systems, or historical or territorial identity (81). Ethnic groups can share a 
belief in a common ancestral origin (81), which also can be a characteristic of a racial group. 
Furthermore, ethnic groups tend to promote marriage within the group, which creates an 
expectation of biological cohesion regardless of whether that cohesion existed in the past (82). 
Ethnic groups may come into existence and then dissolve as a result of broad historical or 
social trends. Individuals might change ethnic groups over the course of their life, or identify 
with more than one group. A researcher, clinician, or government official might assign a certain 
ethnicity to an individual that is quite different from the one that person would acknowledge 
(79). Also, ascribing an ethnic identity to a group can imply a much greater degree of 
uniformity than actually exists (83).  
 18 
 
 
Despite attempts to distinguish “ethnicity” from “race,” the two terms are often used 
interchangeably (84). Individuals can be assigned to population categories in many different 
ways, and which way is the most appropriate is a questions that is still being investigated 
(85,86). In public health, race and/or ethnicity or other equivalent terminology has been 
traditionally used for several different purposes, such as to describe vital and health statistics, as 
a risk indicator for health outcomes, to improve the delivery of health services, as a marker of 
unmeasured biological differences, and as a proxy for unmeasured social indicators (87). In 
scientific studies the applied proxy for ethnicity is highly dependent on the availability and 
completeness of information. However, despite its validity limitations with regard to cultural 
and ethnic identity, country of birth is the most commonly used and accepted proxy, and is 
therefore used in this thesis (88). Country of birth is as relevant an indicator for exposure to 
risk factors as ethnicity, but the advantage with country of birth is that it doesn’t change over 
time and can usually be determined with good precision (unlike ethnicity). Except for genetic 
characteristics, factors related to culture can be accessed by ethnicity and country of birth (1). 
 
 Cultural factors in the epidemiology of disease 2.1.6
Cultural factors such as specific beliefs and behaviours, can cause, contribute to, or protect 
from disease. Cultural factors are not independent or isolated factors, and should be placed in 
their specific contexts, which may include poverty, social inequality and gender relations. 
Economic situation, marriage patterns, sexual behaviour, contraceptive patterns, pregnancy, 
and childbirth practices are all cultural factors that may be of relevance in epidemiological 
studies. Cervical cancer is a well-documented example of the role of these factors, first and 
foremost the role of sexual norms and behaviour in the distribution of a disease (89).  
 
Various studies have shown that cervical cancer is extremely uncommon among nuns and 
common among sex workers. It was originally thought that a woman’s sexual behaviour 
alone could determine her risk of cervical cancer. However, in the 1980s Skegg et al (90) 
showed that in some communities, such as Latin America, a woman’s risk of getting the 
disease depends less on her sexual behaviour than on that of her husband or partner. 
Therefore sexual behaviour in the whole society is of interest, including that of men (90). 
Sexual behaviour includes age at first sexual intercourse, whether premarital or extramarital 
sexual relations are encouraged or forbidden, whether these sexual norms apply to men, to 
women or both, whether contact with sex workers is socially acceptable, which sexual 
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practices are regarded as acceptable, and whether there are taboos on sexual intercourse 
during pregnancy, menstruation, lactation, or puerperium. Although, cultural beliefs and 
practices play a role in a woman’s risk of cervical cancer, it is important not to 
overemphasise their importance (89). 
 
 The global movement of people: the immigrants  2.1.7
There is an on-going global movement of people, ideas, services and ideologies in the world 
(89), and this thesis focuses on immigration and immigrants’ countries of birth. Large numbers 
of people are moving across the globe in search of work, refuge, pleasure, or a new life. 
According to the International Migration Report, more people live outside their country of 
birth today than ever before in history, and these numbers are expected to continue to rise. 
The number of immigrants worldwide reached almost 191 million in 2005, which was 3% of 
the world population. There is an increasing concentration of international migrants in high-
income countries; in 2005 60% of the world’s immigrants were in high-income countries. 
Globally, almost half of all immigrants are women. Immigrants are increasingly concentrated 
in certain regions, specifically North America, Asia and Europe (91). Large population flows 
between neighbouring countries is also common. For example, between Mexico and the 
United States, between countries in North Africa and Spain, and between countries in Eastern 
and Western Europe (92). This is also the case between Sweden and Finland, Denmark, and 
Norway (93). 
 
Many immigrants leave their countries of birth voluntarily in pursuit of better economic 
prospects, higher standards of living, improved access to education and health care, and a 
better future. Others are forced to flee due to war, oppression or natural disasters (89). By 
2005, the total number of refugees was approximately 9.2 million (91). The 1951 Geneva 
Convention defines a refugee as a person who is at risk for oppression because of race, 
religion, nationality, or political views, and states that being a refugee is grounds for granting 
asylum. Moreover, many countries acknowledge "alternative protection" on humanitarian 
grounds, which offers protection to people who are not refugees (89). 
 
Most host countries allow family reunification for immigrants under certain conditions. 
Internationally, the legal basis for family reunification is an individual’s right to family life. 
However, what constitutes family reunification and the conditions under which it is 
permissible vary across countries. Generally, a fundamental distinction is made between 
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temporary migrants and those with long-term residence. Aside from highly skilled workers, 
foreigners granted temporary permission to stay, work, or study are usually not allowed to 
bring in their families (94). While most women immigrate as a part of family units, there are 
increasing numbers of women immigrating independently (89). 
 
 Influence of immigration on HPV infection 2.1.8
Immigrants comprise a highly mobile labour force, and widening income differences between 
nationals and immigrants leads to increasing disparities in health and living conditions. 
Employment-related immigration has been characterised as a major contributor to the 
transmission of STIs (95). The vulnerability of immigrant populations to STIs can be 
explained by factors such as immigrant demographics, lack of skills, knowledge and training, 
restrictive policies on acquiring legal residence status and access to health care services, and 
high levels of perceived stigma of STIs and at-risk groups (sex workers). Reduced pressure to 
conform to the social and sexual norms of the country of birth is a consequence of 
immigration, and may further erode traditional prohibitions against non-marital sex, 
potentially predisposing immigrants to exposure to STIs, including HPV. Immigrant men and 
women may be more likely to engage in high-risk sexual behaviour, such as contact with sex 
workers (95,96). 
 
Separation from family and partners, isolation and loneliness, can encourage people to 
engage in high-risk sexual behaviour. The mobility of immigrants itself makes it harder to 
reach them with prevention information, condoms, counselling and testing services or care. 
Immigrants are often socially, culturally, economically and linguistically marginalised, which 
also increases the barriers to health care access (97). 
 
Immigration therefore offers an opportunity for sexual “bridging”, i.e., sexual connections 
that are formed between members of high and low prevalence sub-populations, and provides 
a channel for infection between them. The impact of immigration on sexual behaviour and 
STIs has been documented (98-104). A study in Spain showed that HPV was detected three 
times more frequently among immigrant women compared to non-immigrant women in the 
host country, leading the authors to conclude that an immigrant women’s risk of HPV 
infection corresponds to the risk in their countries of birth (98). Furthermore, immigration has 
been shown to increase the practice of extramarital sex (102). Immigrants more likely to 
contract a STI than non-immigrants (104), are more likely to have three or more casual sexual 
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partners and unprotected sex (103). However, it is neither immigrants nor immigration per se 
that increases immigrants’ risk of contracting STIs, but the trying conditions and hardships that 
many face after emigrating from their country of birth (105-107). 
 
 Sexual behaviour  2.1.9
Sexual behaviour is an important determinant of STI transmission, and contributes 
substantially to the burden of STI-related disease (108-110). Despite the generalisations and 
trends that can be observed across countries, one of the most striking elements of sexual 
behaviour is its substantial heterogeneity both between and within countries, and even within 
local populations. These regional variations in sexual behaviour emphasise the powerful role 
of environmental factors such as poverty, education, and employment in shaping sexual 
behaviour, and their consequences in regard to sexual health (96). 
 
 The immigrant population in Sweden 2.1.10
In 2011, 15% of the population of Sweden was born abroad (93) compared to 4% in 1960 
(71). Sweden opened its boarders to immigrants in 1930. Immigration to Sweden can be 
divided into three phases, the first of which occurred at the end of Second World War (1945-
1960). The immigrant flow consisted mainly of refuges from the Baltic States and Eastern 
European countries. The second phase occurred in the 1950s and 1960s, when Swedish 
industries and the public sector were in need of labour. During this period immigrants came 
predominately from Sweden’s Nordic neighbours, Finland, Denmark and Norway, though 
there were also some from other parts of Europe. When labour force immigration peaked in 
1969-1970, the trade unions demanded more restrictive immigration laws. Thereafter, 
immigrants needed residence, a work permit and a place to live before they immigrated to 
Sweden. The third phase occurred in 1970-1985, and can be seen as a transitional phase from 
labour immigration to refugee immigration and family reunification. Since the 1980s 
immigration to Sweden has been dominated by this third phase. Sweden has accepted large 
groups of refugees from a number of countries, such as Chile, Iran, Lebanon, Poland and 
Turkey. Since the beginning of the 1990s large numbers of people have immigrated to 
Sweden from the former Yugoslavia due to conflicts. The largest groups that immigrate for 
family reunification are from Somalia and Thailand (93). 
 
It is estimated that one-third of Sweden’s immigrants are from Nordic countries, one-third from 
the rest of Europe, and the last third from non-European countries. The majority of Sweden’s 
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immigrants have lived there for more than 10 years, and around 40% have lived there for more 
than 20 years (93). Immigration between the Nordic countries is dependent on the economic 
situation. (72) 
. 
 Socioeconomic status 2.1.11
Socioeconomic status is linked to an extensive range of health problems, including cancer 
(111). Traditionally, socioeconomic status has been determined using education level, 
income, and occupation, all of which have different relationships with various health 
outcomes (112). Education level is one of the most basic components of socioeconomic 
status, since it shapes future occupational opportunities and creates earning possibilities. It 
also provides knowledge and life skills that allow better-educated people to increase their 
access to information and resources, and thereby promote their own health (113). Higher 
income provides means for purchasing health care, better nutrition, housing, schooling, and 
recreation. Independent of actual income levels, the distribution of income within countries 
has been linked to mortality rates (114). Although the association between income and health 
is stronger at lower income levels, the effect of income persists above the poverty level (115).  
 
Occupational class is a more multifaceted variable. One aspect is whether or not one is 
employed, since individuals who are employed tend to be healthier than those who are 
unemployed (116,117). However, it must be kept in mind that some of this association is a 
function of the “healthy worker” effect (112). Among the employed, occupations differ in 
their prestige, qualifications, rewards, and job characteristics, and each of these indicators of 
occupational class is linked to risk of mortality (118). 
 
It has been estimated that socioeconomic status underlies 80% of premature mortality, and that 
health behaviour and lifestyle accounts for about 50% of this (112). Regarding cervical cancer, 
it has been indicated that differences in socioeconomic status can partly explain differences in 
HPV prevalence, and that men's sexual behaviour, particularly contact with sex workers, might 
be a major contributor to the higher HPV prevalence among the poor (119). Differences in 
screening practices by socioeconomic status tend to decrease when participation is encouraged, 
cultural and economic barriers are removed, and social support is offered. In high-income, and 
middle-to-low-income countries alike, women with low socioeconomic status have a higher 
than average risk of cervical cancer, and a lower than average participation in cervical 
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screening (120). In Sweden, the income discrepancies are relatively small and the country has 
a high GDP (121). 
 
 The health care system in Sweden  2.1.12
The health care system in Sweden is highly decentralised and the major funding sources are 
local and national taxes. Privately-financed health care also exists, but remains marginal. 
Sweden is a country with high-quality universal health care and as such it theoretically offers a 
standardised quality of care to all legal residents (122). Health care delivery is dominated by 
hospitals and primary care is given in health centres. In addition to county hospitals, there are 
tertiary university hospitals in each of the six health care regions of Sweden that provide 
highly specialised services and are also teaching hospitals. Within each of the health care 
regions, an oncological centre coordinates cancer care resources, establishes regional cancer 
registers and promotes a series of cancer care and prevention initiatives. There is a strong 
commitment to equal access to care in Sweden, based on the 1982 Health Care Act. To assure 
all cancer patients equal care, ‘cancer care programmes’ for almost all of the different types 
of cancer have been developed, based on standardised management protocols. Nationwide 
cervical screening is available in Sweden (123). According to the recommendations of the 
Swedish National Board of Health and Welfare, women in Sweden are advised to undergo 
cervical screening by Pap smear test conducted by the counties (124). 
 
A report from the Social and Cultural Planning Office of the Netherlands compared health 
care in Australia, Canada, New Zealand, the United States, and 25 European Union Member 
States. Many different indicators were used: waiting time for non-acute care, public 
confidence in health services, and health status (a combination of life expectancy, quality-
adjusted life years as a percentage of life expectancy, infant mortality, and subjectively 
assessed health). The health care systems in France, Sweden, and Austria ranked highest (125). 
However, with regard to public confidence in health care services, Sweden was middle-ranking 
in comparison with other European Union Member States. There have been indications that 
reliable information on public and patient perception of quality of care, and on the ability to 
receive individualised care, is lacking. Inadequate continuity and fragmentary care with long 
waiting lists, resulting in anxiety and uncertainty have been reported (126). 
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 Cervical cancer among immigrants 2.1.13
Immigrants from Nordic and other European countries 
Immigrants from Nordic countries in Sweden (127) have differing risks of cervical cancer, 
with Danish and Norwegian women having an increased risk (standardised incidence rate 
(SIR) 1.64 and 1.33, respectively) and Finnish women having a decreased risk (SIR 0.88) 
compared to Swedish-born women(128). One possible explanation is the difference in HPV 
prevalence between the country of birth and the host country (129). For example, there have 
been indications that HPV prevalence in Danish-born women with normal cervical cytology 
is three times higher than that in Swedish-born women (130), and the risk of cervical cancer 
has been shown to be higher in Denmark (ASR=10.1) than in Sweden (ASR=7.0) and other 
Nordic countries (Finland=3.9, Norway=9.6, Iceland=7.9) (131). Immigrants from former 
Yugoslavia and Eastern Europe residing in Sweden have shown an increased risk of cervical 
cancer (SIR 1.21 and SIR 1.35, respectively). A high proportion of Eastern European 
immigrants with normal cervical cytology and HPV infection (56.1%) was observed in Italy 
(132). 
 
Immigrants from Africa 
In Africa, about 25% of women in the general population are estimated be infected with HPV 
(130). Higher rates of cervical cancer were found among Jewish women of North African 
origin in Israel compared with all other ethnic groups in the country, and the study also 
indicated that this observation is valid for the second generation of North African women. 
The authors suggested that the similar incidence rates (IRs) seen in both generations may be 
attributed to genetic factors that do not change within one generation (133), therefore it has 
been suggested that genetic factors may modify the risk of cervical cancer development after 
exposure to a carcinogenic agent. However, a meta-analysis on the association between the 
polymorphism and cervical cancer in different populations showed inconsistent results (134).  
 
Although cervical cancer is proportionately the most common cancer among women in sub-
Saharan Africa and other high-risk geographical regions (135), a significantly decreased risk 
has been observed among African immigrants in Sweden (standardised incidence rate, SIR 
0.32, 95% confidence interval, CI 0.10-0.74). The authors suggested that this was most likely 
due to the fact that many African women who immigrated were married, and married women 
have a decreased risk of cervical cancer (136-138). 
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One study found no significant difference among African immigrants in France compared to 
French-born women (139). In another study, cervical cancer mortality was observed to be 
significantly lower among Eastern African immigrants in England and Wales compared to 
that in the English- and Wales-born population (relative risk, RR 0.4, 95% CI 0.2-0.7) (140). 
In both these studies (139,140) it was suggested that the results may have been due to the 
relatively higher socioeconomic status of these African immigrants. In Italy, a high burden of 
HPV infection has been reported among immigrants from Western Africa, 55.5% compared 
to 19.4% among Italian women with normal cytology. It was suggested that the higher 
prevalence may reflect either a high viral prevalence in their country of birth or the fact that 
migrant women attending gynaecological clinics are strongly selected to be at high-risk for 
STIs (132). 
 
Immigrants from Asia 
A study of cancer registry data in the United States, a nearly five-fold increased risk of 
cervical cancer has been observed among immigrants from Southeast Asia compared to non-
Hispanic white women. The study also showed that the excess invasive cervical cancer burden 
appears to be concentrated among women 40 years of age and older (141). Furthermore, a 
report from the state of California showed an incidence of cervical cancer among Filipino 
women (age-standardised incidence rate, ASR=8.5/100 000) that was higher than that in 
whites (ASR=7.3/100 000), although not as high as that among Korean (ASR 11.4/100.000) 
and Vietnamese women in California (ASR= 14/100.000) (142). 
 
Immigrants from South and Central America 
Higher age-adjusted IRs and mortality rates for cervical cancer have been reported in the 
Hispanic population in the United States compared with white women (143). However, in a 
more recent population-based study, Hispanic patients had a 26% decreased risk of cervical 
cancer mortality compared to white women (after adjustment for age at diagnosis, histology, 
stage and treatment). This significant increase in survival is thought to reflect the young age at 
diagnosis of Hispanic women, which appears to confer a significant prognostic advantage. The 
equally high rates of cervical screening reported among Hispanics and non-Hispanics may also 
reflect better health care access (144). Because younger women are less likely to have co-
morbid conditions than older women, curative treatment is more often recommended for 
younger women (145).  
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Immigrants from South and Central America residing in Italy have shown an HPV prevalence 
of 62.5% compared to 19.4% among Italian-born women with normal cytology. High-risk 
HPV types accounted for 80% of HPV infections among women from South and Central 
America. This prevalence correlates very well with the high incidence of cervical cancer 
among women born in South and Central America and the Caribbean (60.5 per 100 000) 
(146). A similar increased prevalence of high-risk HPV types was observed in Latin 
American women in Spain compared to Spanish-born women, and resembled more the 
prevalence of their countries of birth (98). 
 
Incidence of cervical cancer was significantly higher among Caribbean immigrants in 
England compared to English- and Wales-born women (RR 1.3, 95% CI: 1.1-1.5) (140). In 
2007-2009 Haitian immigrant women residing in Miami-Dade County had the highest IRs of 
cervical cancer in South Florida (34 per 100 000 women), nearly four times higher than the 
incidence reported for the Miami metropolitan area overall (9 per 100 000 women). The 
prevalence of HPV and high-risk HPV infection was not elevated among women in Little 
Haiti relative to the general population of the United States. However, differences in study 
populations, statistical uncertainty, and HPV sampling and detection methods likely account 
for some of the differences (147). 
 
 Treatment of precancerous lesions and cervical cancer 2.1.14
Once a diagnosis of invasive cancer is set, a stage must be assigned according to the 
International Federation of Gynaecology and Obstetrics (FIGO) classification to indicate the 
clinical extent of disease. The stage of cervical cancer helps determine treatment and 
prognosis (148). Most of these abnormalities clear without treatment, making aggressive 
treatment unwarranted (149). Nevertheless, these abnormalities cannot be overlooked, as 
most precancerous lesions and cancers are diagnosed in women with equivocal or mildly 
abnormal cytology (150). In many countries fertility-sparing treatments for CIN are preferred, 
such as limited excision of the transformational zone and cryotherapy (151). The dominant 
method of treatment in Sweden and globally is loop electrosurgical excision procedure, or large 
loop excision of the transformation zone (152). 
 
Previously the preferred treatment for early-stage invasive cervical cancer was radical 
hysterectomy (removal of the uterus, cervix, parametria, cuff of vagina and utero-sacral 
ligaments). However, recently minimally invasive surgery has become an option for younger 
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women with early-stage cervical cancer who are considering future pregnancy. These 
fertility-preserving procedures consist of either radical conisation, or removal the cervix, while 
leaving the uterus intact (153). The current recommendation for the treatment of 
microinvasive adenocarcinoma is the same as for squamous cell carcinoma.  
 
Radiotherapy is still the primary choice for women with advanced-stage cervical cancer 
(stage II-IV). Standard radiotherapy consists of radical external beam radiation and 
brachytherapy (21). Several randomised studies have shown improvement in survival when 
radiotherapy is combined with chemotherapy, usually cisplatin chemotherapy (21,154). The 
single most important prognostic factor for long-term survival is the clinical stage of disease 
at presentation. Advancing age also impacts survival rates. Stage IA disease presents a range 
of 5-year survival rates from 90-95%, whereas the rates are 80-85% for stage IB, 50-65% for 
stage IIA, 25-35% for stage III and <5% for stage IV disease (148). Most deaths due to 
cervical cancer worldwide occur in middle-to-low-income countries which is mainly due to 
poor access to, and poor quality of cervical cancer prevention and control programmes (155). 
Most women in low-income countries present with advanced-stage disease, which is often 
either untreatable, or suitable only for palliation (156).  
 
 Prognosis of cervical cancer among immigrant women 2.1.15
Immigrant status has been shown to be a risk factor for advanced-stage cervical cancer (11-17). 
However, improved prognosis among Korean, Vietnamese and Filipino women compared to 
non-Hispanic white women in the United States has recently been shown (157), which could 
not be explained despite adjustment for well-established factors that influence prognosis, such 
as age, stage, socioeconomic status and treatment. Another study from the United States 
showed no association between race and medical funding on cervical screening attendance, 
stage at diagnosis, or survival (158). 
 
 Prevention of cervical cancer 2.1.16
Prevention strategies 
There is no universal solution regarding the best sexual health intervention. Most health 
education programmes generally lead to a change in knowledge and attitudes, but have less 
effect on sexual and contraceptive behaviour (159). Hence, the development of HPV vaccines 
may be a major stride in cervical cancer prevention. Two HPV vaccines are currently available: 
a bivalent vaccine that protects against HPV16 and 18, and a quadrivalent vaccine that 
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protects against HPV16 and 18, as well as two non-carcinogenic types that cause genital 
warts (HPV6 and 11). HPV vaccination has been introduced in Sweden and other Western 
countries as primary cervical cancer prevention (160). However, the vaccines do not eliminate 
the need for cervical screening later in life, as 30% of all cervical cancer cases are due to HPV 
types other than 16 and 18. Furthermore, the public health benefits of HPV vaccines offer an 
opportunity to address disparities in cervical cancer incidence, though a substantial decrease 
in the burden of cervical cancer will only be attained if HPV vaccines are accepted and used 
by at-risk populations (161).  
 
Screening 
Secondary prevention of cervical cancer involves cervical screening, the goal of which is to 
detect and treat abnormal or precancerous cervical lesions before they progress to invasive 
cervical cancer. Indeed, early detection of precancerous lesions improves the chances of 
successful treatment, and is important if cervical cancer mortality is to be reduced (162,163). 
The “cervical screening programme” will be referred in this thesis rather than “cervical 
cancer screening programme”. The incidence of squamous cell carcinoma has been 
effectively reduced since the introduction of cytology-based cervical screening, although 
there has been no reduction in the incidence of adenocarcinoma (162,163). Organised cervical 
screening also led to a significant decrease in cervical cancer mortality (21), including 
adenocarcinomas. 
 
Cervical screening programmes have been established in most high-income countries. 
Cervical screening is not only about having a Pap smear (164), but also includes triage of 
equivocal results, colposcopically-guided biopsies of abnormal screening results, decisions on 
whether or not to treat, which treatment to apply, and post-treatment follow-up (including 
eventual return to routine screening intervals when appropriate). Cervical cancer prevention 
programmes vary widely by country (9). Cervical screening was introduced without formal 
evidence of efficacy from randomised trials, but thanks to observational studies that, over 
time, have provided convincing evidence that a large proportion of cervical cancer can be 
prevented (6,21,163,165). 
 
In Sweden, population-based cervical screening was introduced during the 1960s and was 
implemented on a national level in the 1970s (166). The 50-85% reduction in the IRs of 
cervical cancer in the Nordic countries over the last 50 years is mainly a consequence of 
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high-quality organised cervical screening programmes (167). The organised cervical screening 
programme in Sweden is one of the best examples of successful preventive cancer care, with a 
67% decrease in the overall incidence of cancer over a 40-year period. In 1965 the overall 
incidence of cervical cancer declined from 20 cases per 100 000 women (world standard rate) 
in 1965, to 6.6 cases per 100 000 women in 2005 (168).  
 
In the beginning, all women 30-49 years of age (and later those 25-49 years of age) were 
invited to attend every 3-4 years. According to the recommendations of the Swedish National 
Board of Health and Welfare, women 23-50 years of age are advised to undergo cervical 
screening by Pap smear test every 3 years and women 51-60 years of age are advised to go 
every 5 years (124). The overall coverage according to European Union recommendations is 
85% (169), which is the ultimate goal in Sweden (126). In 2007, it was estimated that 79% of 
Swedish women adhered to recommended screening intervals (170), although this proportion 
was slightly lower in women 23-25 (65-70%) and 26-30 years of age (~75%) (171). While 
HPV vaccination will probably play a major role in the primary prevention of cervical cancer 
for young birth cohorts in the future, cervical screening will remain the principal strategy to 
prevent cervical cancer for many decades (172). 
 
Invitation, attendance and coverage 
Invitation letters are used by organised cervical screening programmes in many high-income 
countries to encourage participation among under-screened and unscreened women (21,173-
175). Coverage is defined as the proportion of women within a catchment area who have at 
least one Pap smear within a pre-set time with or without invitation (176). Cervical screening 
attendance is the proportion of women who actually respond to an invitation and have a Pap 
smear taken. Although there are a number of definitions of cervical screening attendance, no 
reference to any national or international standard unanimously defines it (177). According to a 
national report, attendance is defined as any Pap smear taken within 1 year of receiving an 
invitation (176). In this thesis cervical screening attendance corresponds to attendance 
according to the current recommendation for organised cervical cancer screening in Sweden 
(124). 
 
Cervical screening among immigrant women 
While cervical cancer is easily prevented in most cases through regular screening, screening 
is less common among immigrant populations than among women in the host countries. A 
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growing body of evidence indicates that immigrants generally have lower rates of cervical 
screening attendance (178-187), especially immigrant women 50-69 years of age (188). In the 
United States, it was estimated that at least 50% of women diagnosed with cervical cancer 
never attended cervical screening (161,189). A recent audit of the Swedish cervical screening 
programme revealed that women who had not adhered to the recommended screening 
intervals had a more than a two-fold excess risk of developing cervical cancer (190). 
 
Considerable differences in risk of cervical cancer may reflect inequities in cervical screening 
attendance among immigrant women. However, most studies conducted so far have data from 
organised cervical screening programmes alone (178), or opportunistic screening alone (191), 
or questionnaires/in-depth interviews/chart reviews alone (179-187). The main reasons for 
differences in the incidence of cervical cancer among women are disparities in the utilisation 
of cervical screening and/or follow-up services following abnormal results (6,21,163,165), 
which has been specifically shown among immigrant women and women in the host country 
(178-180,192). 
 
Despite numerous studies on sexual health interventions, there is limited research regarding 
immigrant women. A systematic review of studies published in 1990-2006 revealed that 
multicomponent interventions involving the patient and the provider offer the greatest 
potential to increase cervical screening and treatment in immigrant populations (193). 
Prominent interventions include: telephone reminders for screening intervals in the woman’s 
native language coupled with educational messages about cervical cancer, providing 
transportation, using female physicians and interpreters, and establishing coalitions between 
trusted community organisations and screening providers. In order to increase cervical 
screening and education for a particular immigrant population, programme managers and 
clinicians must understand the population’s unique belief system, and modify interventions to 
diminish any underlying factors that may negatively influence cervical screening attendance, 
such as modesty or embarrassment, improper hygiene beliefs, and karma/fate (193). 
Knowledge of cervical screening guidelines is one of the strongest motivators for having a 
Pap smear among all immigrant groups (193,194). Last but not the least, understanding 
differences in cervical screening attendance in high-risk populations with the intention to 
reduce disparities over time is important when evaluating preventive cancer strategies (6).  
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3 AIMS 
The overall aim of this thesis is to study the risk of cervical cancer among immigrant women in 
Sweden, their cervical screening attendance and their prognosis after cervical cancer diagnosis. 
To address this overall aim, the four studies included in the thesis had the following specific 
aims: 
 
I. To estimate the risk of invasive cervical cancer among immigrant women in Sweden. 
The aim was also to evaluate whether the risk of invasive cervical cancer was modified 
by follow-up time and age at immigration. 
 
II. To estimate cervical screening attendance among immigrant and Swedish-born women 
and their subsequent risk of developing cervical cancer. 
 
III. To explore how Danish and Norwegian immigrant women in Sweden reason about 
attending cervical screening, focusing on women’s perceptions as to why they and 
their compatriots do not attend. 
 
IV. To examine the prognosis of cervical cancer among women in Sweden with regard to 
immigrant status, cervical screening attendance and socioeconomic status, as measured 
by occupational class and education level. 
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4 MATERIALS AND METHODS 
4.1 QUANTITATIVE AND QUALITATIVE APPROACHES 
In this thesis both quantitative (Studies I, II and IV) and qualitative approaches (Study III) 
were used. These approaches were chosen as they suited the research aims by providing 
different perspectives, and complemented each other. A range of methods is needed in order to 
understand the complexities of modern health (195-197). The main features of qualitative and 
quantitative approaches are described briefly here.  
 
The quantitative approach involves the analysis of numerical data, with the goal of classifying 
and counting features, and constructing statistical models to analyse the data collected to reveal 
eventual associations in an attempt to explain observations. The goal is to measure and 
determine the relationships among variables. All aspects of the study are carefully designed 
before data is collected. Researchers use tools such as questionnaires or equipment to collect 
numerical data. Data is in the form of numbers and statistics. The purpose is generalisability, 
prediction and causal explanations, and the goal is to measure and determine the relationships 
between variables. The quantitative approach aims to be objective and to render precise 
measurement and analysis of target concepts, e.g., uses surveys, questionnaires etc. 
Quantitative data is more efficient and can be used to test hypotheses, but may miss contextual 
detail. Researchers tend to remain objectively separated from the subject matter (197). 
 
The goal of the qualitative approach is to present a complete, detailed description, and involves 
analysis of data such as words (e.g., from interviews) and pictures (e.g., video). The design 
emerges as the study unfolds. The purpose is contextualisation, interpretation and 
understanding participants' perspectives. The researcher is the data gathering instrument. The 
research method, for example in-depth interviews, is subjective, as importance is placed on the 
individual’s interpretation of events. Qualitative data is rich, complex and time-consuming to 
collect. One of the most common misconceptions about qualitative research is that the sample 
size is too small to allow generalisation of findings. Although it is true that qualitative 
findings cannot be generalised in the same way quantitative findings can be, i.e., through 
statistical inference, qualitative findings are generalisable to settings that are similar to those 
under investigation. The degree to which a given study setting is similar to a setting outside a 
study depends on how many of their key factors are similar. Depending of the level of 
similarity, the findings can be viewed either as lessons that can be applied to other settings, or 
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simply as working hypotheses (198). The researcher is intensely engaged in the process before, 
during, and after data collection (197). 
 
The quantitative approach was employed in Studies I, II and IV, using a cohort study design 
due to the nature of the research aims. The respective goals were to estimate the risk of invasive 
cervical cancer among immigrant women (Study I), to estimate cervical screening attendance 
among immigrant and Swedish-born women in Sweden (Study II), and to examine the 
prognosis of cervical cancer among immigrant women (Study IV). The research aim of Study 
III was to understand women’s reasoning regarding cervical screening attendance. Thus the 
explorative character of the study required a qualitative approach with FGDs. The quantitative 
studies allowed us to examine the relationships among variables. As the quantitative approach 
is not effective when it comes to exploring these relationships, the qualitative approach was 
used in an attempt to explain the factors underlying the broad relationships between variables. 
 
4.2 REGISTER-BASED STUDIES AND THE PERSONAL IDENTITY NUMBER 
Sweden is a country that provides unique, exceptional opportunities in the way of register-
based studies, which is mostly due to the systematic use of the PIN, which is assigned to all 
Swedish citizens at birth, and to legal residents (199). The 10-digit PIN is maintained by the 
Tax Agency for all individuals who have lived in Sweden since 1947. A unique PIN is created 
for each person, consisting of six digits for birth year, month and day, combined with four more 
digits. The PIN remains the same throughout a person’s lifetime, and does not change if you 
move from or to Sweden (200). The Swedish health care system and national health registers 
are dependent on the PIN (199). 
 
The quality of Swedish registers is very high, due to both the long history of collecting 
population-based data, which provides an excellent base for monitoring disease, and to the 
ability to link individual information from different population-based registers through the PIN. 
A register is a complete list of people in a certain population. Information about the identity of 
these individuals has to be available so that the register can be updated, and new variables 
added if applicable. These registers are stored in databases. Registers either consist of data 
collected from national surveys, or are administrative registers complied by different national 
authorities and organisations. Longitudinal studies are studies where a group of individuals are 
followed during a set period of time. All registered individuals in Sweden can be followed via 
their PIN, which can be used to link information on different variables from different registers. 
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When performing linkages, the number of individuals changes over time as people are born, 
move or die. The theoretical concepts in the research aim have to be operational, which means 
they can be translated into conceptualised measures. In the TPR a variable has been created to 
determine whether individuals are foreign-born or native-born, using four other variables, 
including the person’s country of birth, duration of residence in Sweden, and father’s and the 
mother’s country of birth. 
 
When death and emigration is not reported, it results in over-coverage, while unreported births 
and immigration result in under-coverage in the register. In addition to these issues of coverage, 
there may also be issues with irrelevance. One important aspect of irrelevance is the difference 
between the population of interest and the target population. There are probably about 25 000-
50 000 legal Swedish residents who do not live permanently in Sweden. Estimates show that 4-
8% of non-Nordic immigrants have left Sweden without reporting it (201).  
 
4.3 INTERNATIONAL CLASSIFICATION OF DISEASES 
Cervical cancer diagnoses are coded according to the International Classification of Diseases 
(ICD), a statistical classification system used to group diseases and causes of death. The ICD is 
a standard diagnostic tool for epidemiological, health management and clinical purposes, 
including the analysis of the general health of population groups. It is used to oversee the 
incidence and prevalence of diseases and other health problems, and also provides the basis for 
national mortality statistics in the Member States of the World Health Organisation (202). In 
Studies I, II and IV, the 7th revision of the ICD (ICD-7) was used.  
 
4.4 STUDY DESIGNS IN THE THESIS 
A cohort study is an epidemiological study design (quantitative), which was used in Studies I, 
II and IV (Table 1). All cohort studies used longitudinal, based on national Swedish data that 
comprised immigrant women (defined as women with different countries of birth) or Swedish-
born women.  
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Table 1. Summary of the materials and methods used in Studies I, II and IV 
 Study I Study II Study IV 
Design  Cohort study Cohort study Cohort study 
Subjects Women:  
Immigrant/Swedish-born  
Women:  
Immigrant/Swedish-born 
Women:  
Immigrant/Swedish-born  
with a diagnosis of  
invasive cervical cancer 
Number of women 
Immigrant/Swedish-born 
758 002/4 737 549  445 547/2 176 255  
 
2535/23 681  
Inclusion criteria for age 
(years) 
13-100 23-70 15-99 
Time period  
(years) 
1968-2004 1993-2005 1960-2005 
1993-2005 
Data sources TPR 
The Migration Register 
The National Swedish 
Cause of Death Register 
NCSR 
NCSR‡ 
TPR 
The Migration Register 
The National Swedish Cause 
of Death Register 
The Swedish Cancer 
Register 
TPR 
The Swedish Cancer Register  
The National Swedish Cause 
of Death Register 
1960, 1970, 1980 and 1990 
Swedish Censuses 
The National Swedish 
Education Register 
NCSR 
Exposure Immigrant status 
Country of birth 
Immigrant status 
Country of birth 
Age at immigration 
Participation in cervical 
screening  
 
Immigrant status 
Country of birth 
Cervical screening 
Household occupational class 
Education level 
Outcomes Invasive cervical cancer  
 
 
Degree of cervical screening 
participation 
 
IRRs† 
Death due to cervical cancer 
 
 
Analysis Poisson regression 
model stratified by 
follow-up time, age at 
immigration, country of 
birth 
Poisson regression model 
stratified by adherence to 
cervical screening, age at 
immigration, country of 
birth  
Cox proportional hazard 
model 
 
‡NCSR: National Cervical Screening Register 
† IRR: incidence rate ratio 
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In Study III, a qualitative study design with FGDs was used to collect data (Table 2). 
  
Table 2. A summary of the materials and methods used for Study III 
Design and method Qualitative explorative design with FGDs 
Subjects and number of 
individuals 
Immigrant women: 27 Danish/13 Norwegian 
Inclusion criteria for 
age (years) 
23-70 
Time period (year) 2010 
Data sources Stockholm: Data collected via FGDs of recruited participants of immigrant 
women living in the Stockholm area  
Aim To explore how Danish and Norwegian immigrant women in Sweden 
reason about attending cervical screening, focusing on women’s 
perceptions as to why they and their compatriots do not attend. 
Analysis Latent content analysis 
 
 Cohort study design (Studies I, II, IV)  4.4.1
A cohort study is an observational study that follows all individuals in a source population over 
time. The subjects are classified according to their exposure status (exposed and non-exposed) 
to investigate a given outcome (203). Cohort studies can either be prospective or retrospective. 
In a retrospective cohort study, data is gathered for a cohort that was formed sometime in the 
past; records have been kept, and all exposures and outcomes have already occurred. The 
incidence of disease can thereby be studied over time by the IR. Cohort studies provide 
information about the cause of disease and the most direct measure of the risk of developing 
disease. Cohort studies are major undertakings and may require long periods of follow-up, as 
disease may occur long after exposure (204).  
 
The cohort study design was a good fit for Studies I, II and IV because of the uniqueness of the 
register data available in Sweden. Studies I, II and IV were all retrospective cohort studies with 
prospective follow-up of individuals. The PIN easily enabled linkages of the registers used, and 
records of country of birth and date of immigration were almost complete. Swedish registers 
provided an essentially complete follow-up and enabled identification of almost all incident 
cervical cancer cases that occurred during the study periods.  
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 Focus group discussions (Study III) 4.4.2
For Study III FGDs were conducted to collect data about attitudes, experiences, and 
conceptions (205). FGDs can also be used for sensitive questions  if certain criteria are met 
(206). In this study the FGD participants were offered the possibility to ask questions after 
the FGD, and if they were interested, they were provided with information on cervical cancer 
and cervical screening, and told where to go if they had additional questions or needed to 
discuss any issues more in-depth. The use of FGDs gave a more profound understanding, as it 
allowed us to explore how Danish and Norwegian immigrant women in Sweden reason about 
attending cervical screening, focusing on their perceptions as to why they and their 
compatriots do not attend. We also chose immigrant women from Central America and 
Middle Africa, who had the highest risk of cervical cancer among all immigrants in Sweden, 
and low cervical screening attendance compared to Swedish-born women (Table 3). 
However, results from these groups are not included in this thesis, as the recruitment process 
was challenging in different ways. Therefore analyses in Study III were based only on FGDs 
among Danish and Norwegian immigrant women (Table 3). 
 
Table 3. Overview of data collection in FGDs of immigrant women 
Country/region of 
birth 
 Method  
 
 
Total 
number of 
participants 
FGD 
(Number of 
participants) 
Personal 
interview 
Telephone 
interview 
Denmark 5 (27) 1 2 30  
Norway 3 (13) 3 10 26  
Middle Africa 5 (21) 4 2 27  
Central America 5 (23) 3 2 29  
Total  18 (84) 11 15 112  
 
 
4.5 STUDY SETTING 
 Swedish population (Studies I, II, IV) 4.5.1
Studies I, II and IV comprised national Swedish data. Sweden is a long, narrow country that 
comprises 21 counties and is sparsely populated. The population is unevenly distributed 
across the country, with the largest proportion of people living in the southern parts. (72). At 
present, Sweden has a total population of about 4.8 million women, 15% of whom were born 
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outside Sweden and have immigrated to the country (19). In 1960, only 4% of the population 
was born outside Sweden.  
 
 Stockholm population (Study III) 4.5.2
The participants in Study III were Danish and Norwegian women living in the Stockholm area. 
Stockholm is the capital of Sweden, the Stockholm area hosts a population of 1 055 390 
Swedish-born women and 233 489 (22%) immigrant women. The proportion of immigrants in 
Stockholm is higher than in the rest of the country (207). 
 
4.6 DATA SOURCES (STUDIES I, II, IV) 
Studies I, II and IV all involved data from a linkage of seven Swedish nationwide registers, 
namely the TPR, the Swedish Cancer Register, the Swedish Cause of Death Register, the 
Migration Register, the National Cervical Screening Register (NCSR), the Swedish Education 
Register and the Swedish Censuses (1960, 1970, 1980 and 1990). Information on follow-up 
time and age at immigration offered the possibility to evaluate the effect of time spent in 
Sweden. 
 
 Swedish Total Population Register and Migration Register 4.6.1
The TPR is the basic register of the population of Sweden. Population registration in Sweden 
has a long history and was originally administered by the church; the oldest preserved church 
registers are from the early 17th century. Nowadays, the TPR is administered by the Tax 
Agency in Sweden, which receives most of the information from other public agencies. Data 
from this register contains, among others, PIN, place of birth, citizenship status, marital 
status, name of spouse, name of children, name of parents, address, municipality in which 
you are registered, immigration to and emigration from Sweden, address abroad and vital 
status (200). In 1968, when population statistics in Sweden were computerised, the Migration 
Register was created by Statistics Sweden based on information in the TPR, comprising 
information on immigration and emigration (72). 
 
 Swedish Cancer Register 4.6.2
The Swedish Cancer Register was established in 1958 and covers the entire Swedish 
population. It is mandatory for every health care provider (physicians as well as 
pathologists/cytologists) to report newly detected cancer cases to the register. There are six 
regional registers associated with the oncological centres in each medical region of Sweden, 
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where registration, coding and major checking of the information is performed. This regional 
process allows for the maintenance of close contact between the register and the reporting 
physician, which in turn simplifies the checking correcting of information. There are three 
different types of information in the Swedish Cancer Register: data on the patient (e.g., PIN, 
sex and place of residence), medical data (e.g., tumour site, histological type and date of 
diagnosis) and follow-up data (e.g., date of death and cause of death) (208). 
 
 Swedish Cause of Death Register 4.6.3
The Swedish Cause of Death Register was established 1749 when a nationwide report system 
for deaths was initiated. Today, The National Board of Health and Welfare is responsible for 
Swedish mortality statistics. Cause of death is classified according to the ICD (209). The 
register covers all deaths since 1997. However, in 0.5% of all deaths the Board of Health and 
Welfare was not able to obtain a death certificate. Information on these deaths is still included 
in the Cause of Death Register, but without any medical information. Whenever possible, the 
cause of death is registered for Swedish residents, whether the deceased was a Swedish 
citizen or not, and whether the death occurred in Sweden or abroad. Non-residents who died 
in Sweden, and Swedish residents who emigrated and are not registered as living in Sweden, 
are not included in the statistics (209). The main variables included in the register are PIN, 
sex, date of birth, date of death, place of residence, cause of death and whether death 
occurred abroad (210). 
 
 National Cervical Screening Register 4.6.4
In Sweden the initiation of an organised cervical screening programme started between the late 
1960s and the end of 1970s (165,166). In the beginning all women 30-49 years of age were 
invited to attend every 3-4 years. Since the end of 1990s, women have been invited every third 
year from 23-50 years of age and every fifth year thereafter until 60 years of age. The NCSR 
includes information on cytological and histological diagnoses, and the laboratory where the 
samples were analysed. Longitudinal information on cervical screening in Sweden, starting 
from 1970 and encompassing the entire country as from 1995, are included in the NCSR. 
Information on cervical screening attendance, and date of Pap smear comprises information on 
Pap smears taken both within and outside the organised cervical screening programme (170). 
Recently, the NCSR was renamed the National Quality Register for Cervical Cancer 
Prevention (211). 
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 Swedish Censuses 4.6.5
The Swedish population and housing censuses are a count of the population taken by the 
government primarily for demographic, or taxation purposes. The censuses include 
enumeration of the population, apartments and households, families and cohabitation, 
occupational information, employment, income, and socioeconomic status. The type of data 
requested in the censuses is based on a questionnaire to the public, and available registers, and 
varies between the censuses (207). The data are collected by Statistics Sweden in cooperation 
with the Tax Agency, municipalities and church offices. Though it is required by law to 
provide census information, the completeness was 97.5% in the 1990 Swedish Census. One 
of the main reasons given for not providing complete information was invasion of privacy 
(207).  
 
Information on occupations are coded and verified with the Occupational Register (212). 
Information on occupation is also compared with information from the employer. The 
completeness in both the 1960 and 1980 Census was 99%, whereas in the 1990 Census it was 
98% (213-215). 
 
 Swedish Education Register 4.6.6
The Swedish Education Register was initiated in 1985. The register consists of graduation and 
educational background data from the censuses and is updated each year with 
graduation/examination data from educational institutions in Sweden. The register contains 
demographic information from the TPR and educational data in addition to the PIN (216). The 
register comprises the population 16-74 years of age registered as residents in Sweden as of 1 
January of each year. The register contains data on demographics and education, in addition to 
the PIN, which is necessary to link to other registers for updating purposes. The main variables 
are age, sex, municipality of residence, country of birth, highest attained education level and 
completion year (217). The data on highest attained education level is matched with the TPR 
for the actual population 16-74 years of age living in Sweden on 1 January. The register carried 
out special surveys called “education completed abroad” in 1995 and 1999, including people 
20-59 years of age born in countries other than Sweden, where data on attained education level 
was missing. The purpose of the study was to improve the statistics on education completed 
abroad. Since 2000, an annual questionnaire is administered to newly-immigrated individuals 
who were born outside Sweden, who have missing information on education level (217). 
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4.7 DATA COLLECTION (STUDY III) 
 Focus group discussion guide 4.7.1
The research team, which consisted of midwives, public health experts, epidemiologists and a 
medical doctor, developed the FGD guide. It was used in FGDs of immigrant women from 
different countries of birth, with different socioeconomic status and who lived in different 
parts of Stockholm. The final version was pilot tested on another group of immigrant women 
who were students at Karolinska Institutet.  
 
The FGD guide included mainly open-ended questions related women’s perception of health, 
disease and prevention, cervical cancer, cervical screening and obstacles and motivators to 
attend cervical screening. Questions included, for instance, “How did you experience 
receiving the invitation letter?”, “How important is having a Pap smear to you?” and “Why 
do you think some women do not have a Pap smear?”. 
 
 Moderators 4.7.2
Two moderators, who were native speakers of Danish and Norwegian, respectively, were 
enrolled to lead the discussions. The purpose of this was to encourage the participation of 
women who were hesitant to participate due to language problems, and also to facilitate 
discussion by offering the opportunity for the participants to discuss in their own language if 
they so wished for clarity of thought. The Danish moderator worked as a research assistant 
and the Norwegian moderator was a midwife who worked in a clinical setting. The 
moderators were trained for 8 hours on two different occasions in subjects related to cervical 
cancer and cervical screening attendance among immigrant women in Sweden, and how to 
handle different situations that could arise during FGDs. The FGD guide was also discussed 
with the moderators during their training. Data was collected between April and May 2010 at 
Karolinska Institutet. 
 
All participants completed a questionnaire that collected their background data before the 
FGDs started. The participants were also offered light refreshment prior to the FGD. They all 
understood Swedish, and were encouraged to speak Swedish during the discussion, although 
they were aware of the possibility to speak their native language if the need presented itself. 
When necessary, due to the more or less developed Swedish linguistic refractive of the 
immigrant women, clarification was requested by either the moderator or the assistant, either 
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in Swedish, or in the native language. While it rarely occurred, if participants gave a response 
to a clarifying question in their native language, the moderator translated the response into 
Swedish and confirmed the translation with the participant. This was possible given the 
linguistic similarity between Nordic countries. Therefore, the transcripts used for this analysis 
contained Swedish-language responses only.  
 
The FGDs began with a short presentation by the moderator, followed by a brief presentation 
of the study and the guiding principles of the discussion. The moderator led the discussion 
and made sure that all participants had a chance to voice their thoughts. The discussions were 
tape recorded but an assistant also took notes, which included a description of the discussion 
environment, keywords of what the participants said, and anything of value regarding the 
quality of the FGD with special attention paid to the interaction between participants. It was 
also the role of the assistant to ask follow-up questions on issues that needed clarification at 
any time during the FGD. 
 
A summary based on the notes and a debriefing session between the moderator and the 
assistant were also tape recorded immediately after each FGD. The FGDs lasted 1 to 1½ 
hours, during which time the women talked openly and freely. The moderator balanced the 
discussion so that all topics in the FGD guide were evoked. The FGD participants were 
offered the possibility to ask questions after the FGD, and if they were interested, they were 
provided with information on cervical cancer and screening, and told where to go if they had 
additional questions or needed to discuss any issues more in-depth. All participants were 
offered a gift as a token of appreciation: they could choose between two movie tickets or a 
gift certificate to a flower shop worth 150 Swedish Kronor.  
 
4.8 STUDY PARTICIPANTS AND SAMPLING (STUDIES I, II AND IV)          
Studies of immigrant groups represent individuals or families that move or are forced to move 
from one environment to another. This thesis comprises a study population of immigrant 
women from168 different countries. 
 
 Study I 4.8.1
There were 6 713 558 women registered in the TPR during the period 1968-2004. We used 
the PIN to follow the cohort members through linkages to the Swedish Cancer Register, the 
Cause of Death Register and the Migration Register. To analyse the at-risk population, we 
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excluded girls who were younger than 13 years of age at the end of the study period (8%) and 
women who were 80 years of age or older at cohort entry (1.5%). In addition, we excluded 
women who died (3.9%), emigrated (3.6%) or had a history of cervical cancer (0.1%) before 
cohort entry, and immigrants for whom information on country of birth or date of 
immigration were missing (0.7%). Because PINs of women who die are occasionally reused 
for newborn children or immigrants, we further excluded cohort members who were older 
than 100 years of age during follow-up (0.3%). Our final study sample comprised 4 737 549 
Swedish-born and 758 002 immigrant women who were followed until a diagnosis of 
cervical cancer, death, emigration from Sweden, or December 31, 2004, whichever came 
first. 
 
 Study II 4.8.2
The TPR was used to establish a cohort of women who were alive and residing in Sweden at 
some point during the period 1993-2005. Immigrant status (whether women were born 
outside Sweden and had immigrated, or were Swedish-born) was obtained from the TPR. The 
PIN was used to link the cohort to the Swedish Migration Register, Cause of Death Register 
and the Swedish Cancer Register. 
 
Follow-up commenced at 23 years of age, date of immigration to Sweden or 1 January 1993, 
whichever came last. Women with a date of emigration from Sweden, women who died, and 
those with cervical carcinoma in situ or invasive cervical cancer before cohort entry were 
excluded (1.0%). Immigrant women with no information on country of birth or date of 
immigration were also excluded (0.04%). Women 23-60 years of age were eligible to enter 
the study, and were followed until 70 years of age, a diagnosis of invasive cervical cancer, 
cervical carcinoma in situ, date of emigration from Sweden, death, or December 31, 2005, 
whichever came first. The study cohort was matched to the NCSR, and longitudinal records 
of cervical screening attendance were obtained. Pap smears taken beyond the screening ages 
of the organised screening programme (23-60 years of age) or beyond the study period (1993-
2005) were not counted in this study. In addition, Pap smears taken within 6 months of 
diagnosis were not counted in a woman’s screening history, as it would not have been 
possible to prevent the existing invasive cancer. For this reason, we excluded 9530 Pap 
smears from a total of 10 948 015 (0.09%). The ICD-7 code 171 was used to identify 
invasive cervical cancer cases.  
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 Study IV 4.8.3
Women with a diagnosis of cervical cancer recorded in the Swedish Cancer Register during 
the period 1960-2005 were included. Immigrant status was identified through the TPR. 
Linkages between the Swedish Cancer Register and the TPR, as well as other data sources, 
were carried out. Information on occupational class for the study women and the members of 
their household was retrieved from the 1960, 1970, 1980 and 1990 Swedish Censuses. 
Information on education level was also retrieved from these censuses and from the 1985 
Swedish Education Register. Date and cause of death were retrieved from the Swedish Cause 
of Death Register and information on cervical screening attendance and dates of Pap smear 
were retrieved from the NCSR. ICD-7 code 171 was used to identify cases of invasive 
cervical cancer. Death from cervical cancer was identified based on the ICD-7 code 171 in 
1960-1968, ICD-8 code 180 in 1969-1986, ICD-9 code 180 in 1987-1996, and ICD-10 code 
C53 in 1997-2005. Deaths among women with unspecified uterine cancers and a previous 
diagnosis of cervical cancer were included as deaths from cervical cancer.  
 
We identified 26 237 women diagnosed with cervical cancer in Sweden between 1 January 
1960 and 31 December 2005. We excluded cases with unknown country of birth (n=20) and 
implausible ages (n=1). The final study sample comprised 23 681 Swedish-born (90%) and 
2535 immigrant (10%) women, who were followed up until date of death, date of first 
emigration from Sweden, or end of follow-up (31 December 2005), whichever came first.  
 
4.9 STUDY PARTICIPANTS AND SAMPLING (STUDY III) 
The target population for Study III was immigrant women 23-70 years of age from Denmark 
and Norway living in the Stockholm area. Since the goal was to get a deeper understanding of 
women’s reasoning regarding cervical screening in general, there was no special effort made 
to recruit only non-attenders. Previous studies showed us that less than 50% of immigrant 
women adhere to the screening intervals recommended by the Swedish National Board of 
Health and Welfare for cervical screening.  
 
A list of women 23-70 years of age residing in Stockholm County was obtained from the 
Swedish Tax Agency. Sampling was then done in two steps. First, we randomly selected 440 
Danish (of 1258 eligible) and 400 (of 2612 eligible) Norwegian immigrant women from the 
list using a computer sampling programme. These numbers were chosen based on previous 
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experiences of low response rates when recruiting FGD participants. The selected women 
were contacted by mail and asked to participate in the study; they could respond by email or 
phone. As expected, very few women responded (<5). Therefore in a second step all 
randomly-selected women who had not responded were contacted by phone and asked if they 
were interested in participating in the study. However, phone numbers for 72 Danish and 98 
Norwegian immigrant women could not be retrieved, so these women were sent a second 
letter reminding them of the study and asking them to send their contact information. None of 
these women responded. Fifty-three Danish women and 28 Norwegian women accepted to 
participate in the FGDs. However, at the last minute 26 and 15 women, respectively, were not 
able to attend due to illness, work or other social priorities.  
 
Most women who were contacted by phone either did not respond, despite repeated calls, 
were not interested in participating in the study, expressed interest but were hindered by a 
variety of practical and logistical obstacles, or declined to participate in the FGDs but agreed 
to be interviewed individually. These women were interviewed individually, but data from 
these interviews are not included in this thesis. In total, five FGDs with 27 Danish 
participants, and three FGDs with 13 Norwegian participants, were conducted (Table 4). 
Each focus group consisted of three to seven participants, who were assigned to an FGD by 
country of birth and age group (23-40 years and 41-70 years). The intention was to attain 
homogeneity in the group in order to facilitate an open atmosphere. Preliminary analysis was 
done continuously, in parallel with data collection. A minor change to the FGD guide was 
made in the initial phase of data collection. 
 
4.10 DATA ANALYSIS FOR STUDIES I, II AND IV 
SAS statistical software was used in all data analyses in Studies I (version 9.1), II (version 9.2) 
and IV (version 9.3). In Studies I and II, Poisson regression models were used, while in Study 
IV Cox’s proportional hazards models were used.  
 
 Regression modelling 4.10.1
Regression models and stratification are the two main statistical procedures that are used in 
data analysis to deal with confounding. In order to adjust simultaneously for several 
confounders, regression modelling methods may be necessary. Regression models summarise 
the relationship between an outcome (dependent) variable and one or several explanatory 
(independent) variable(s) as a mathematical equation. There are different types of regression 
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models, which are commonly used in epidemiological studies. One of the most important 
advantages of regression models is that all explanatory variables are treated in the same way, 
and it does not require one to define which explanatory variable is the exposure and which are 
the potential confounders. While Poisson regression models are used to estimate rate ratios 
using person-time data (Studies I and II), the Cox proportional hazards model is used when the 
time to an event is the main interest, such as in survival analyses (Study IV) (218). 
 
Poisson regression model (Studies I and II) 
The Poisson regression model is used to describe the probability of occurrence of count data 
during a set period of observation. The RR is the probability that a member of an exposed 
group will develop a disease relative to the probability that a member of an unexposed group 
will develop the same disease. In cancer research, RR is used in prospective (forward looking) 
studies, such as cohort studies. A RR of one means there is no difference between two groups 
in terms of their risk of cancer, based on whether or not they were exposed to a certain factor. 
A RR greater than one means that being exposed to a certain factor increases the risk, 
whereas a RR less than one shows a decreased risk.  
 
Poisson regression model (Study I) 
Exposure information: 
The main variable was being an immigrant or Swedish-born woman living in Sweden, as per 
data obtained from the TPR. Immigrant women from 168 different countries were categorised 
into 19 birth regions based on the United Nations Population Division, a classification 
previously used by the International Agency for Research on Cancer to provide global cancer 
statistics (Globocan 2002) (219).  
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Figure 1 Map Showing the World Areas Studied in Globocan 2002. 
From Parkin et al (8) 
 
Because of intercountry variations within these regions, the countries were further 
categorised into low-, medium- and high-risk regions for cervical cancer according to the 
ASRs (less than 10, 10-20 and >20 per 100 000 women, respectively). If there were more 
than 10 000 immigrants from a particular country, or if there were fewer but from a country 
with an ASR different than those of the other countries in their region, they were studied 
separately. For all categories of risk regions average ASRs were calculated from the country-
specific ASRs provided by Globocan 2002.  
 
In Study I Poisson regression models were used to estimate RRs and corresponding 95% CIs 
among immigrant women compared to Swedish-born women, adjusted for attained age and 
calendar period in 5-year categories. Immigrant women may have prevalent cancers at the time 
they arrive in the host country, which could lead to biased estimates. Therefore the analyses 
were repeated after excluding the first 2 years of follow-up. Because this restriction did not 
change the results notably, all the available data were used in the analyses. 
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Poisson regression model (Study II) 
Exposure information: 
The main exposures were cervical screening attendance and country of birth. Women were 
classified as being an immigrant or Swedish-born as previously described in Study I. In Study 
II the RR, IR and incidence rate ratio (IRR) of cervical cancer for women who did and did not 
get screened according to the recommendations of organised cervical screening programme in 
Sweden were reported. 
 
Cervical screening (Study II) 
Women were assumed to be non-attenders at cohort entry unless they had record of screening 
within the 6 years before cohort entry. Women 23-50 years of age were considered to be 
attenders for 3 years from the date of their last Pap smear, while women 51-60 years of age 
were considered to be attenders for 5 years after their last Pap smear. These time intervals 
correspond to the screening schedule of the organised cervical screened programme in Sweden 
(124,170). Three or 5 years after a Pap smear test, women were considered non-attenders 
unless they had another registered Pap smear. Non-attenders with a Pap smear would shift to 
the group of participants, and vice versa. Women who attended cervical screening at the last 
invitation after 55 years of age were assumed to be attenders until the end of follow-up. Women 
who attended screening regularly were assumed to be participants throughout follow-up, while 
other women provided risk time for both the attendance and non-attendance groups based on 
their screening history. Women who had no record of screening (neither organised nor 
opportunistic screening) during follow-up were assumed to be non-attenders throughout the 
follow-up period. To estimate the risk of cervical cancer for attending and non-attending 
women, cervical cancer cases and person-time of adherence and non-adherence to the cervical 
screening programme was summed for immigrant women, and for Swedish-born women. 
 
Relative risk of cervical cancer (Study II) 
RRs of cervical cancer and corresponding two-sided 95% CIs among immigrant women 
compared to Swedish-born women, stratified by adherence to the cervical screening 
programme, and adjusted for attained age (in 5-year categories), were also estimated. Finally, to 
evaluate whether differences in the RR of cervical cancer between immigrant women and 
Swedish-born women were due to adherence to cervical screening, Poisson regression models 
were fitted. The RR of cervical cancer was assessed among all immigrant women compared to 
Swedish-born women, as well as among selected groups of immigrant women where the power 
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was considered sufficient (at least 5 cancer cases during follow-up). The models were adjusted 
for attained age (in 5-year categories), calendar period (in 5-year categories) and county (all 21 
counties in Sweden), and then further adjusted for screening adherence as a time-dependant 
covariate. The same type of models were also fitted among immigrant women only, to evaluate 
whether any differences in the risk of cervical cancer, depending on age at immigration, were 
due to adherence to cervical screening.  
 
The incidence of cervical cancer (Study II) 
Incidence refers to the number of new cancer cases that occur in a defined population of 
disease-free individuals. To calculate the IR, the varying lengths of follow-up time need to be 
taken into account. The follow-up time is the sum of time each individual remained under 
observation for developing the disease, and ends early when and if they become a cancer 
case. This time is viewed as the person-time at risk and is expressed as person-years. The sum 
of all individuals’ time at risk equals the total person-years at risk (218). 
 
 
IR= 
number of new cases of disease arising in a defined  
population over a given period of time 
total person-time at risk during that period 
 
Crude IRs may be calculated for the whole population, or IRs can be calculated separately for 
specific sub-groups (strata) of the population, referred to as stratum-specific measures. Age-
specific IRs are an example of a stratum-specific measure, and can be used to gain greater 
epidemiological understanding of the disease under study. Age-specific IRs can be calculated 
as follows (218): 
 
 
 
 
In Study II the impact of adherence to cervical screening on the incidence of cervical cancer 
were assessed by calculation of age-specific IRs of cervical cancer for immigrant and 
Swedish-born women, stratified by adherence to screening (Figure 2). 
 
Age-adjusted incidence of cervical cancer (Study II) 
Crude IRs are influenced by the underlying age distribution of a country’s population. Even if 
two countries have identical AIRs, the country with the relatively older population will 
Age-specific IR 
per 100 000       = 
person-years 
number of new cases in an age group of a defined 
population over a specific period of time 
person-years at risk in that age group in the same 
population and during the same period of time 
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generally have higher crude IRs, as IRs for most cancers increase with age. The age distribution 
of a population (i.e., the proportion of people in particular age categories) can change over time 
and can be different in different geographical regions. The use of AIRs ensures that differences 
in incidence over time, or between geographical regions, are not due to differences in the age 
distribution of the populations being compared. AIRs of cervical cancer stratified by adherence 
to the cervical screening programme, were calculated for the immigrant group and for Swedish-
born women using Poisson regression models in Study II.  
 
Incidence rate ratios of cervical cancer (Study II) 
IRRs, adjusted for attained age, where the absolute risk of cervical cancer for non-adherent 
women was compared to that of adherent women, were estimated for each immigrant group 
and Swedish-born women in Poisson regression models in Study II. IRRs use the difference 
in IR rates to provide a better estimate of the effects of intervention (or treatment) in groups 
under study that have different lengths of follow up. Thereby, the IRR provides a relative 
measure of the effect of a given intervention and is derived as the IR of the intervention 
group divided by the IR of the non-intervention group. 
 
Cox proportional hazards model (Study IV) 
In Study IV the data were analysed using Cox proportional hazard models using calendar time 
(days) since diagnosis as the time scale to calculate differences in risk of mortality adjusted for 
known confounders. The Cox proportional hazards model is one of the most commonly used 
statistical methods in medical time-to-event studies (220) and is one form of survival analysis. 
The hazards function is another name for IR and is based on time to event. Survival analysis 
focuses on the distribution of survival times and examines the relationship between survival 
and one or more predictors, usually termed covariates. Survival analysis is suitable for data 
from a cohort study design. The main effect measure is the hazard ratio (HR) and is defined as 
the hazard in the exposed group divided by that in the unexposed group. 
 
The Cox proportional hazards model assumes that the hazards for patient subgroups are 
proportional throughout follow-up. Since this is a strong assumption, its applicability should 
always be evaluated. There are different methods to evaluate the proportionality assumption, 
such as plotting the log cumulative hazards function over time and checking for parallelism. In 
Study IV the Kaplan-Meier estimate was used, one of the best options to measure the fraction 
of women living up to 10 years after cervical cancer diagnosis, and the survival curve was 
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calculated. The time starting from a defined point to the occurrence of a given event, which was 
death in Study IV, is called survival time. Survival time can be affected when some of the 
subjects experience neither the event nor death before the end of the study, though they would 
have if observation continued, or if they could not be followed up and were lost midway in the 
study. We label these situations as censored observations. The Kaplan-Meier estimate 
computes survival over time in spite of the difficulties associated with subjects and situations.  
 
The immigrant women included in Study IV were from 76 countries, which were classified 
into 12 regions/countries of birth. For the purposes of this analysis, immigrant women were 
considered together (all immigrants), separated into Nordic- and non-Nordic categories, or 
separated into regions/countries of birth as detailed in Table 4. 
 
Table 4 Definition of regions/countries of birth used in Study IV 
Region/country of birth Countries included in the regions/countries of birth 
Africa
 Ethiopia, Angola, Morocco, Algeria, South African Republic, Egypt, 
Botswana, Somalia, Republic of Mauritius, Republic of Madagascar.  
America
 Uruguay, Brazil, Ecuador, Bolivia, Argentina, Peru, Chile, Colombia, Costa 
Rica, El Salvador, Honduras, Barbados, USA, Canada.  
Asia and Australia
 Turkey, Vietnam, Indonesia, Lebanon, Iraq, Jordan, Syria, Palestine, 
Taiwan, Iran, India, Thailand, China, Republic of Korea, Philippines, 
Afghanistan, Israel, Singapore, Sri Lanka, Japan, Australia.  
Denmark Denmark 
Norway Norway 
Finland Finland 
Baltic states
 Latvia, Lithuania, Estonia. 
Germany
 Germany 
Former Yugoslavia
 Bosnia Herzegovina, Croatia, Macedonia, Slovenia, Yugoslavia. 
Other Europe
 Iceland, Ukraine, Poland, Spain, Hungary, Austria, Czech republic, 
Romania, United Kingdom and North-Ireland, Portugal, Greece, Russian 
Federation, Soviet Union, Italy, Belgium, France, The Netherlands, Bulgaria, 
Switzerland. 
 
In Study IV analyses were first run un-adjusted and then adjusted for age at diagnosis in 5-year 
categories, calendar time at diagnosis in 10-year categories (1960-1969, 1970-1979, 1980-
1989, 1990-1999 and 2000-2005) and county of residence at diagnosis. The HRs of 10-year 
mortality risk due to cervical cancer were estimated for the time period 1960-2005, with 
corresponding 95% CIs, by country/region of birth. 
The national coverage of register data for cervical screening was almost complete for the period 
1993-2005 and therefore we performed analysis of cervical screening on a subset of the data 
restricted to this period. Furthermore, HRs and corresponding 95% CIs were estimated among 
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Swedish-born and immigrant women separately, by household occupational class and 
education level; in separate models cervical screening attendance was also added. Separate 
analyses were also used to test if age at immigration modified the effect of education level on 
mortality risks. All tests of statistical hypothesis were considered significant on the two-sided 
5% level of significance. 
 
Prognosis and history of cervical screening 
We assessed the history of cervical screening attendance prior to cervical cancer diagnosis as 
a proxy for clinical stage at diagnosis (221). Women were considered screening-detected 
cases if they had a Pap smear 1-6 months prior to diagnosis. All other women were 
considered symptomatic cases. Women with Pap smears taken within 1 month of diagnosis 
were also considered symptomatic cases. Symptomatic cases were divided into three groups: 
those with a Pap smear within the recommended screening interval, those with Pap smears 
beyond the screening interval, and those with no registered Pap smears.  
 
Prognosis and occupational class and education level 
Household occupational class and women’s education level were utilised as indicators of 
socioeconomic status. Household occupational class was determined using the “dominance 
order” (222) to retrieve information about the highest occupational class in the household 
prior to cervical cancer diagnosis, and was mainly based on information regarding the index 
woman and her cohabitants (husband, companion or other adult). The housing identification 
number from the censuses was used to find women’s cohabitants. Household occupational 
class was classified into eight categories: high non-manual, low non-manual, high manual, 
low manual, self-employed, farmer, unclassifiable, and not in the labour force. Missing 
occupational information was included as a separate category. Women’s highest education 
level prior to cervical cancer diagnosis was used and classified into three categories: high (13 
years or more of schooling), medium (10-12 years of schooling) and low (9 years of 
schooling or less). Missing education level was included as a separate category. 
 
 Stratification 4.10.2
Stratification is another way of dealing with confounding in data analysis. Stratification 
divides data as strata based on a potential confounding variable. More specifically, 
confounding is controlled when the association of interest is evaluated within distinct, 
relatively homogeneous subgroups (strata) constituted by individuals with respect to the 
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confounding variable (223). Stratification was used in Studies I and II, and will be described 
in detail for each study. 
 
Follow-up time and age at immigration 
To evaluate the change in risk of cervical cancer in the host country in Study I, the effect of 
living less or more than 10 years in Sweden was analysed, assuming that 10 years in the host 
country would be sufficient to affect the risk of cervical cancer. In these analyses, all the 
immigrant women contributed person-time from cohort entry until 10 years of follow-up, and 
were switched to a new cohort if they stayed more than 10 years in Sweden, after which they 
were followed until the end of the study period. The analyses in Study I were also stratified by 
age at immigration (≤30 or >30 years of age). The statistical test of homogeneity is a statistical 
evaluation of the extent to which variation in the estimates of the strata is consistent with 
random behaviour and represents a decision to simplify analysis and reporting of effect 
modification. The test of homogeneity examines the hypothesis that the estimate has a 
constant value across the strata (203). P-values for the interaction between country of birth and 
follow-up time, and age at immigration, respectively, were calculated in the regression model. 
 
Further stratifications for follow-up time and age at immigration were done for the immigrants 
from the Nordic countries and the Baltic States, as this data had reasonable power. In these 
analyses, median values of follow-up time and age at immigration in each stratum was used to 
test for trends. The test for trend is a statistical test that assesses whether the outcome measure 
tends to increase or decrease in value as the exposure score increases. The test considers the 
null hypothesis, which means that the measures are not associated with the exposure score. 
Therefore, a small p-value means the association was detected by the test (203). 
 
 The age-standardised incidence rates (Study I) 4.10.3
When comparing cancer IRs between two areas with two different populations, it is important 
to take into consideration differences in the age structure of the populations. Age-
standardisation is a method that uses a hypothetical population, referred to as the standard 
population, the age-structure of which is known. In the standardisation process the 
populations in each age group of the standard population are known as the weights. The 
standard population enables comparisons of disease incidence that are controlled for 
differences in the age structure of the study populations (218). In Study I, we estimated the 
ASRs for different groups of immigrants in Sweden using the age distribution of the world 
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standard population, and compared these rates with the ASRs provided by the Globocan 2002 
database (224). 
 
4.11 DATA ANALYSIS FOR STUDY III 
 Content analysis  4.11.1
Manifest content analysis focuses on what the text really says, whereas latent content analysis 
tries to catch the underlying meaning (225,226). However, Graneheim et al also stated that both 
manifest and latent analyses are interpretations with variations in depth and level of abstraction 
(225). In Study III, manifest content analysis was used when analysing the data. Latent content 
analysis was used to build the theme based on the categories derived in the manifest content 
analysis. The aim of the theme was to communicate the underlying meaning of the text (225).  
 
The basis of content analysis are meaning units, i.e., words, sentences or paragraphs 
containing aspects that are related to each other through their content and context. In Study 
III paragraphs were used. This was followed by the analysis phase, which includes the 
process of condensation, i.e., the process of shortening the text while still preserving the core 
(225,227). The process whereby the condensed text is abstracted has been called abstraction, 
because it entails descriptions and interpretations on a higher logical level. This phase 
includes the formations of codes, categories and themes. The creation of codes is the process 
of labelling the condensed meaning unit with a code that represents a descriptive level of 
content and can be seen as an expression of the manifest content of the text. The theme is 
referred to as the interpretative level of the underlying meaning, through condensed meaning 
units, codes or categories (225). A description of the analytic process is displayed in Table 4. 
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Table 4 Examples of the analytical process 
Meaning unit (participants quotes) Condensed meaning unit Code Sub-Category Category Theme 
[D] 
“P2: I mean this is the way I think, I have so little…I should have 
done it [had the Pap smear] when I should have, and if I had been 
in Denmark then I would have had seven [Pap smears], I would 
have been there seven times. Now I attended once in seven years, 
sort of. So that…yes, I wasn’t proud of myself, no I am not. 
 
 
 P2: All the people were new and so was everything, for me it 
was like...went from being single to being married. Went from 
not having any children to taking care of three children. Went 
from studying to having a job. So everything was new all at 
once. So I was so completely exhausted when I went to bed and I 
didn’t dream for two years. And then you receive all this 
information in the letterbox, “welcome to this thing” and 
“welcome to that” and now you can become Swedish and 
everything in through the door. (…) Well it was a bit like that, 
that’s to say all this stuff that comes in through the door is 
impossible to relate to. There were so many other things you 
should….”  
 
In Denmark had a pap smear once per year but 
after the move to Sweden had once in seven 
years. 
 
Doesn’t feel proud not having had a Pap smear 
 
 
Feeling there were so many changes in life when 
moving to Sweden that you get a sense of 
exhaustion 
 
 
 
Hard to relate to all information that comes in 
through the door in the letterbox. There were 
so many other things you should... 
 
  
 
Postponing cervical screening 
attendance-changed behaviour 
related to immigration. 
 
Negative feelings not having had 
the Pap smear 
 
Competing needs related to the 
move to Sweden 
 
 
 
 
Prioritisation of needs 
 
 
Postponing cervical 
screening attendance 
 
 
Psychological factor 
 
 
Competing needs related 
to immigration 
 
 
 
 
Competing needs related 
to immigration 
 
 
Postponing cervical 
screening attendance 
 
 
Previous experiences, 
psychological and 
individual factors 
Competing needs 
related to immigration 
 
 
 
 
Competing needs 
related to immigration 
 
Women have a 
comprehensive 
rationale for 
postponing 
cervical 
screening, yet 
do not view 
themselves as 
non-attenders 
 
[F]  
“P:5: I will not do it [have a Pap smear] -so I waited for the next 
invitation as I said and there was someone who said of course you 
should do it! I think it was my Mum who said it, you must go and 
do it, it is very important. Oh, it is? But does it hurt? (…) ” 
 
”P:4. I thought they explained very well why you should have a 
pap smear, so I went at once.” 
 
 
K: What was it that made you think no? 
 “P5: So the pain, does it hurt? I was worried about that. And I 
don’t know if there was anything in the letter to explain to me 
why, but anyhow I did not read it because I have a bit of problem 
reading and taking in information that I am not interested in. I 
don’t read it, it is difficult for me.”  
 
 
 
“So no, I was just worried that it would hurt. But it wasn’t so bad 
when I had it done. I felt a little bit on...there were three spatulas 
they scraped with so now I feel that now yes...now I shall go. “ 
 
 
Thought that no I will not do it [have a Pap 
smear] -so waited for the next invitation  
The Mum said you must go and do it [have a 
Pap smear], it is very important. 
 
Good explanation in the letter [why have a Pap 
smear]-went at once. 
 
 
Worried to feel pain when having a Pap smear 
and therefore didn’t want to [have a Pap smear]. 
Didn’t know if there was anything in the letter 
to explain why you should have a Pap smear, 
but did not read it anyhow. 
Have problem reading and taking in 
information that you are not interested in- it is 
difficult for you. 
Worried to feel pain when having a Pap smear 
It wasn’t so bad having a Pap smear. You felt a 
little bit so now you feel that you will have 
your Pap smear.  
 
Waited for the next invitation 
 
´Reminded by a relative 
 
 
Good information in the invitation 
-motivates having a Pap smear. 
 
 
Afraid that having a Pap smear 
should hurt. 
 
 
Tiresome read and understand 
written information. 
 
 
Afraid that having a Pap smear 
should hurt. 
Having had pap smear despite fear. 
Positive experience-motivated 
having Pap smear 
 
Postponing cervical 
screening attendance 
Social support-motivation 
 
 
Organisational and 
structural factors- 
Motivation 
 
Psychological factor 
 
 
Individual factor 
 
 
 
Psychological factor 
 
Previous experiences, 
psychological factor 
 
Postponing cervical 
screening attendance 
Social support-
motivation 
 
Organisational and 
structural factors- 
motivation 
 
Previous experiences, 
psychological and 
individual factors 
 
 
Women have a 
comprehensive 
rationale for 
postponing 
cervical 
screening, yet 
do not view 
themselves as 
non-attenders 
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5 ETHICAL CONSIDERATIONS 
All studies included in this thesis received ethical clearance before study commencement. 
Ethical clearance for Study I was given by the Regional Ethics Committee at 
Karolinska Institutet, and for Studies II, III and IV by the Regional Ethics Committee in 
Stockholm.  
 
The database information in the register-based studies was anonymised after the 
necessary linkages were conducted, thereby ensuring that the women included could not 
be identified. The analyses in the quantitative studies (Studies I, II and IV) were 
presented as statistical calculations and as numbers in tables, in which any specific 
individuals are not identifiable. The PIN was used to follow cohort participants through 
linkages to the registers used in each study (Studies I, II and IV). For confidentiality 
purposes, instead of PINs, a unique identification number was used and assigned to 
each woman by Statistics Sweden. Therefore no names or PINs were provided to the 
researchers by Statistics Sweden.  
 
In Study III the participants were informed about the aim of the study, and were informed 
that participation was voluntary. Verbal consent was obtained from all participants, and 
the FGDs were tape recorded after acceptance by the participants. During the explanation 
of the guiding principles of the FGDs, the moderators also urged the women to respect 
the personal nature of the discussion, and to maintain confidentiality by not discussing 
the information brought up during the FGDs outside the group. The incentives used in 
this study are considered to be too small to have motivated women to participate (228), 
and were used more as tokens of appreciation. All summaries and presentations were 
conducted in such a way that no specific individual can be identified. FGDs can also be 
used as an appropriate method for posing sensitive questions (206). However, certain 
requirements in the data collection procedures must be met. The FGD participants were 
offered the possibility to ask questions after the FGD if they were interested they were 
provided with information on cervical cancer and cervical screening, and told where to 
go if they had additional questions or needed to discuss any issues more in-depth. 
 
The law of secrecy applies to all those in the research group. A written agreement for 
professional secrecy was signed by the moderators, the assistants and the transcriber of 
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the data. The possible harm caused by violation of privacy of the participants in all studies 
comprised by this thesis should be considered minimal. 
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6 MAIN FINDINGS 
6.1 AGE-STANDARDISED RATES OF CERVICAL CANCER 
Comparison of the ASRs of cervical cancer between immigrant women in Sweden and 
women in their countries of birth revealed a mixed pattern. The ASRs for most 
immigrant women in Sweden were lower than that in their countries of birth. However, 
the ASR for Central American immigrant women remained as high as in their country 
of birth (ASR 31.4 per 100 000 women). Immigrant women from medium-risk 
countries in Northern Europe (ASR 11 per 100 000 women), the low-risk country 
Turkey (ASR 7 per 100 000 women), and medium-risk countries in Northern Africa 
(ASR 17.3 per 100 000 women) had higher ASRs in Sweden than the Globocan 2002 
estimates. ASRs among immigrant women from Denmark, Norway and Finland were 
considerably higher than in their countries of birth (Table 5). 
 
Table 5: ASRs for immigrant women from Denmark, Norway and Finland in Sweden, 1968-2004.  
Birth region/country ASR 
Globocan 2002 Sweden 
 Denmark 12.6 17.2 
 Finland 4.3 9.1 
 Norway 10.4 15.8 
 Sweden 8.2  9.3 
 
6.2 RELATIVE RISK OF CERVICAL CANCER (STUDY I) 
After adjustment for age and calendar period, we observed increased risks of cervical 
cancer among immigrant women from European countries compared to Swedish-born 
women; the highest RRs were found among immigrant women from Denmark (RR 1.8, 
95% CI 1.6-2.1) and Norway (RR 1.7, 95% CI 1.5-1.9), followed by women from 
Romania (RR 1.6, 95% CI 1.0-2.4), the former Yugoslavia (RR 1.4, 95% CI 1.2-1.6) 
and Poland (RR 1.3, 95% CI 1.1-1.5). Among immigrant women from non-European 
countries, we observed decreased risks for women from Eastern Africa (RR 0.2, 95% 
CI 0.1-0.6), South Central Asia (RR 0.4, 95% CI 0.2-0.6) and Western Asia (RR 0.5, 
95% CI 0.4-0.7). RRs were significantly higher among women from Middle Africa (RR 
3.0, 95% CI 1.0-9.3), Central America (RR 2.5, 95% CI 1.3-4.9), Chile (RR 1.5, 95% 
CI 1.1-2.0) and high-risk countries of South Eastern Asia (RR 1.8, 95% CI 1.2-2.7), 
compared to Swedish-born women. 
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6.3 RELATIVE RISKS BY FOLLOW-UP TIME AND AGE AT IMMIGRATION 
(STUDY I) 
 Follow-up time 6.3.1
Analysis of follow-up time among all immigrant women combined revealed a 
significantly lower RR after living more than 10 years in Sweden (RR 1.03, 95% CI  
0.97-1.10) than during the first 10 years of follow-up (RR 1.25 95% CI  1.17-1.33; 
p<0.0001). It is noteworthy that excess RRs among immigrant women from most 
European countries significantly decreased toward the same risk as Swedish-born 
women after 10 years of follow-up. A significant increasing trend was observed among 
immigrant women from Western Asia who had lived in Sweden for more than 10 years 
(p=0.006). 
  
Further stratification of follow-up among immigrant women from Nordic countries 
revealed that the RRs among these women continued to decrease the longer they lived 
in Sweden. The RR of 1.1 in the first 10 years among Finnish women dropped to 0.7 
after living in Sweden for 30 years (p for trend=0.01). 
 
Table 6. RRs and corresponding 95% CIs of invasive cervical cancer among immigrant women 
from the Nordic countries in Sweden compared to the Swedish-born women, stratified by follow-
up time and age at immigration, 1968-2004 
 Denmark 
(cases n=193) 
Finland 
(cases n=620) 
Norway 
(cases n=256) 
All immigrants 
(cases n=1991) 
Overall  1.8 (1.6-2.1) 1.0 (0.9-1.1) 1.7 (1.5-1.9) 1.13 (1.08-1.18) 
Follow-up time (year)     
 <10  2.3 (1.9-2.7) 1.1 (1.0-1.2) 1.9 (1.6-2.2) 1.25 (1.17-1.33) 
 10-19 1.8 (1.3-2.3) 1.0 (0.9-1.1) 1.5 (1.2-1.9) 1.04 (0.96-1.13) 
 20-29 1.4 (1.0-2.0) 0.9 (0.8-1.1) 1.5 (1.1-2.0) 1.02 (0.92-1.14) 
 ≥30 1.2 (0.7-2.2) 0.7 (0.5-1.0) 1.7 (1.1-2.6) 0.98 (0.82-1.17) 
P-value for trend 0.3 0.01 0.4 <0.0001 
Age at immigration 
(year) 
  
 
 
 <30 1.4 (1.0-1.9) 0.8 (0.7-0.9) 1.6 (1.2-2.1) 0.90 (0.83-0.97) 
 30-49 1.7 (1.4-2.1) 0.9 (0.8-1.0) 1.5 (1.3-1.8) 1.07 (1.00-1.14) 
 ≥50 2.9 (2.2-3.8) 1.8 (1.6-2.2) 2.1 (1.7-2.6) 1.75 (1.60-1.91) 
P-value for trend 0.01 0.07 0.2 <0.0001 
     
 
 Age at immigration 6.3.2
Analyses stratified by age at immigration showed that calendar period and age-adjusted 
RR of cervical cancer among all immigrant women who came to Sweden when they 
were over 30 years of age was significantly higher than that among Swedish-born 
women (RR 1.25, 95% CI 1.17-1.32). We observed striking excess RRs among 
immigrant women who were older than 50 years of age at immigration from the Nordic 
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countries and the Baltic States. Furthermore, we observed a significantly increasing 
trend by age at immigration for Danish women (p=0.01). It is worth noting that the RR 
was significantly higher even among Finnish women who were older than 50 years of 
age at immigration (RR 1.8, 95% CI 1.6-2.2), who otherwise showed no overall excess 
risk relative to Swedish-born women. 
 
6.4 ASSESSMENT OF CERVICAL SCREENING (STUDIES II AND III) 
 Cervical screening attendance (Study II) 6.4.1
On average, mean adherence to cervical screening at recommended screening intervals 
was 62% for Swedish-born women, whereas it was 49% for immigrant women, and 
there was a higher proportion of immigrant women who did not attend screening at all. 
However, there was a large variation in cervical screening attendance within, and 
between immigrant groups. Mean cervical screening attendance ranged from about 32% 
among immigrant women from Australia and New Zealand up to 58% among Finnish 
immigrant women. 
 
Additional analyses, stratified by age at immigration, revealed that cervical screening 
attendance was inversely associated with age at immigration, being highest among 
those who immigrated when they were younger than 30 years of age, and then generally 
decreasing with increasing age at immigration. However, this pattern varied between 
immigrant groups. Among women from Chile, the highest attendance was seen among 
women who immigrated at 20-49 years of age, whereas women from Eastern Africa 
had a low cervical screening attendance even at a young age at immigration. Immigrant 
women from the United States, Canada, Australia, and New Zealand who were 20 years 
of age or older at immigration had a very low cervical screening attendance. 
Immigrants who moved to Sweden after 50 years of age invariably showed the lowest 
cervical screening attendance.  
 
 Cervical screening and the incidence of cervical cancer (Study II) 6.4.2
To assess the impact of cervical screening attendance on the incidence of cervical 
cancer, we calculated age-specific IRs of cervical cancer for immigrant and Swedish-
born women, stratified by screening attendance (Fig. 1). The age-specific IRs of 
cervical cancer were similarly low (below 10 per 100 000 women) among immigrant 
and Swedish-born women who attended cervical screening. For non-attenders, the 
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incidence of cervical cancer increased rapidly from 25-30 years of age, peaking at 40-
50 years of age (around 35 cases per 100 000 women). Incidence increased and peaked 
at an older age (5-10 years later) among immigrant non-attenders compared to 
Swedish-born non-attenders. 
 
Figure 2 Age-specific IRs (cases per 100 000) among Swedish-born (thick lines) and immigrant 
women (thin lines) who attended screening (dotted lines) and did not attend screening (solid lines) 
in Sweden, 1993-2005. 
 
 
 Cervical screening and age-adjusted incidence rate (Study II) 6.4.3
The AIRs of cervical cancer were extremely low among both immigrant (age-adjusted 
IR 3.1 per 100 000) and Swedish-born (age-adjusted IR 4.3 per 100 000) women who 
attended cervical screening, whereas immigrant and Swedish-born non-attenders 
showed AIRs of 16.9 and 21.7, respectively. Among all immigrant women, the RRs of 
cervical cancer were significantly lower both among women who did not attend 
cervical screening (RR 0.8, 95% CI 0.7-0.9) and those who did (RR 0.7, 95% CI 0.6-
0.9) compared to Swedish-born women. Among non-attenders from the Baltic States 
(Estonia, Lithuania and Latvia) and Norway, the RR of cervical cancer was not 
significantly different from that of Swedish-born women. However, among women 
from these countries who did attend cervical screening, the RR was significantly higher 
among women from Norway (RR 2.3, 95% CI 1.2-4.5) and the Baltic States (RR 3.9, 
95% CI 1.5-10.4). Women who were non-attenders from Western Asia (RR 0.3, 95% 
CI 0.2-0.5) and South Central Asia (RR 0.3, 95% CI 0.1-0.6) showed significantly 
lower RRs whether or not they attended cervical screening in Sweden (attenders 
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Western Asia: RR 0.3, 95% CI 0.1-0.8; attenders South Central Asia: RR 0.1, 95% CI 
0.0-0.8). 
 
 Cervical screening and incidence rate ratio of cervical cancer 6.4.4
(Study II) 
Differences in IRRs of cervical cancer for women who did not, compared to women 
who did, attend cervical screening were more than five-fold, both among immigrant 
women (IRR 5.4, 95% CI 4.3-6.8) and Swedish-born women (IRR 5.1, 95% CI 4.7-
5.5). The point estimates for IRRs were noticeably higher (although they had wide CIs) 
among immigrant women from Denmark (IRR 10.3, 95% CI 2.4-44.9), Poland (IRR 
9.4, 95% CI 3.7-24.3), high-risk areas in South America (IRR 15.8, 95% CI 2.0-123.7), 
Turkey (IRR 17.1, 95% CI 2.2-132.1), South Central Asia (IRR 12.4, 95% CI 1.6-99.1) 
and high-risk areas in South Eastern Asia (IRR 15.2, 95% CI 2.0-116.9).  
 
 Cervical screening and relative risk of cervical cancer (Study II) 6.4.5
The RR of cervical cancer among all immigrant women, stratified by age at 
immigration to Sweden, showed increased risks for those who immigrated between at 
40-49 years of age (RR 2.0, 95% CI 1.4-2.8) and at 50 years of age and above (RR 2.2, 
95% CI 1.3-3.7), compared to women who immigrated at 20-29 years of age. Adjusting 
for cervical screening attendance decreased the RR by 20-30% among those 40-49 
years of age (RR 1.6, 95% CI 1.2-2.3). However, for women who immigrated before 20 
years of age, the risk of cervical cancer increased after adjustment for cervical 
screening attendance (RR 1.4, 95% CI 1.1-1.7). 
 
Immigrant women from Norway and the Baltic States showed statistically significantly 
increased risks of cervical cancer, compared to Swedish-born women, in both the group 
that did not (RR 1.7 and 2.3, respectively) and that did attend cervical screening (RR 
1.5 and 2.0, respectively). Immigrant women from the former Yugoslavia also showed 
a significantly increased risk of cervical cancer (RR 1.4, 95% CI 1.1-1.8), but after 
adjustment for screening attendance the RR decreased slightly and was no longer 
statistically significant (RR 1.2, 95% CI 0.9-1.4). We observed strikingly decreased 
risks of cervical cancer for women from Western Asia and South Central Asia (RR 0.3, 
95% CI 0.2-0.5 and 0.1-0.5, respectively) compared to Swedish-born women, both 
before and after adjustment for screening attendance. 
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 How immigrant women reason about cervical screening (Study III) 6.4.6
Another perspective of the assessment of cervical screening in this thesis focused on 
exploring how women reason about cervical screening and more specifically what 
reasons they attribute to themselves and to their compatriots for not attending. “Women 
have a comprehensive rationale for postponing cervical screening, yet do not view 
themselves as non-attenders”, was the main theme that summarised the views of Danish 
and Norwegian immigrant women who took part in this qualitative study. This view was 
apparent even when women had postponed their attendance for several years. The main 
theme was generated from eight categories that seemed to influence the delay in cervical 
screening attendance. The key findings showed categories that were viewed by the 
women to be related to immigration, such as competing needs due to immigration, but 
also organisational and structural factors, and differences in mentality. Other categories 
that were discussed by the women were previous experiences, psychological and 
individual factors, childbearing-related factors, social support and social network, and 
risk perception. However, for some women these factors were considered to enable 
cervical screening attendance. The women described these factors as being intertwined 
when discussing their reasoning for postponing cervical screening attendance, thereby 
revealing the underlying complexity of this issue.  
 
Postponing cervical screening attendance was the core category that linked all the reasons 
why women didn’t attend cervical screening more promptly after receiving the invitation 
letter from the organised cervical screening programme. It was discussed in all groups 
that women who were invited to participate in cervical screening justified postponing it 
according to their personal rationale. As they described it, cervical screening attendance 
was given low priority at the time, and they therefore waited to attend, forgot about it, 
had the intention to attend later on, thought that they would attend after receiving the next 
invitation, or simply put it aside. 
 
Immigration to Sweden per se seemed to influence our participating Danish and 
Norwegian immigrant women not to adhere to recommended screening intervals. The 
women discussed specifically how their energy and focus were consumed by the change 
of environment, attempts to learn how different societal systems worked in the new 
country, and to their resettlement efforts, all of which are related to competing needs due 
to immigration.  
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Women mentioned that organisational and structural factors also negatively influenced 
cervical screening attendance. The aspects brought up by the women were differences 
between the health care system in their country of birth and that in Sweden, the 
perception of the cervical screening invitation system as impersonal, logistical challenges 
and the importance of having a relationship with their caregivers. 
 
The women also discussed how differences in mentality influenced their cervical 
screening attendance. In this category, the reasons why women delayed their cervical 
screening attendance were related to their perception of large differences between their 
country of birth and Sweden, which led to overwhelming experiences that were energy-
consuming. Other reasons discussed were the reluctance of women to accept regular 
health controls and governmental involvement in private life, and a more anxious 
approach towards things one should or should not do in Sweden in comparison with a 
more easy-going approach in their country of birth.  
 
6.5 PROGNOSIS OF CERVICAL CANCER (STUDY IV) 
The distribution of different types of cervical cancer among Swedish-born and immigrant 
women was similar, with squamous cell carcinoma being the predominant histological 
type (around 80% of all cases). The investigation of how the prognosis of women with 
cervical cancer was influenced by immigrant status, cervical screening attendance, 
occupational class, and education level showed that immigrant women had a slightly 
lower risk of cervical cancer mortality than Swedish-born women (HR 0.9, 95% CI 0.8-
0.9). The point estimate remained the same when adjusted for age, calendar period and 
county of residence at diagnosis. However, when the analysis was stratified by 
region/country of birth, a 20% lower risk of mortality was observed in the adjusted 
analysis among non-Nordic immigrants (HR 0.8, 95% CI 0.7-0.9) compared to Swedish-
born women, while it did not differ among Nordic immigrant women. 
 
The excess risk of mortality was four-fold (HR 4.1, 95% CI 3.3-5.2) among symptomatic 
cases with no history of cervical screening attendance, while symptomatic cases 
diagnosed within or beyond the screening interval showed a three-fold increased risk of 
mortality (HR 3.0, 95% CI 2.3-3.8 and HR 3.3, 95% CI 2.6-4.3, respectively). The 
pattern was the same when stratification by immigrant status was performed. 
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An excess risk of cervical cancer mortality was observed among both Swedish-born and 
immigrant women with a low education level, independent of history of cervical 
screening attendance. The effect of education level on prognosis of cervical cancer 
showed that Swedish-born women with a medium education level had a 30% excess risk 
of mortality (HR 1.3, 95% CI 1.1-1.6), and those with a low education level had a 60% 
increased risk of mortality (HR 1.6, 95% CI 1.4-2.0), compared to those with a high 
education level. Immigrant women with a low education level had a more than two-fold 
statistically significant excess risk of mortality (HR 2.2, 95% CI 1.2-3.8) compared to 
those with a high education level. Immigrant women with missing information on 
education level showed a nearly three-fold excess risk of mortality before adjustment for 
history of cervical screening attendance (HR 2.7, 95% CI 1.4-5.1), although adjustment 
for this variable did not change the estimates notably. 
 
This pattern was also seen among Swedish-born women with low manual household 
occupational class, women from households not in the labour force and women with 
missing information on occupational class. Swedish-born women from households that 
were not in the labour force showed an 82% increased risk of mortality (HR 1.82, 95% 
CI 1.40-2.36) compared to Swedish-born women from high non-manual households. 
After adjustment for history of cervical screening attendance, this excess risk remained 
(HR 1.74, 95% CI 1.34-2.25). Swedish-born women with low manual household 
occupational class had a slightly increased risk of mortality (HR 1.23, 95% CI 1.04-1.47, 
before and HR 1.20, 95% CI 1.01-1.43 after adjustment for history of screening 
attendance). Swedish-born women with missing information on occupational class had a 
51% increased risk of mortality before adjustment for history of screening attendance 
(HR 1.51, 95% CI 1.02-2.24), but results were no longer significant after adjustment for 
this variable (HR 1.37, CI 0.92-2.03). 
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7 DISCUSSION 
7.1 SUMMARY 
The overall aim of this thesis was to study the risk of cervical cancer among immigrant 
women in Sweden, their cervical screening attendance and their prognosis after cervical 
cancer diagnosis. Study I showed which groups of immigrant women were at high risk 
for cervical cancer, and demonstrated that both age at immigration and follow-up time 
modifies the risk of cervical cancer. To further increase the understanding of immigrant 
women’s cervical screening attendance, Study II was carried out, which showed that 
immigrant women attend cervical screening less than Swedish-born women. Adherence 
to recommended screening intervals was shown to be strongly associated with cervical 
cancer prevention. Following the results of Study II, it was decided to qualitatively 
explore how Danish and Norwegian immigrant women in Sweden reason about attending 
cervical screening, focusing on women’s perceptions as to why they and their 
compatriots do not attend, which became the object of Study III. Investigation of 
women’s rationale for non-attendance after being invited to cervical screening revealed 
some complex reasons related to immigration itself, including competing needs, but also 
organisational and structural factors, and differences in mentality between the country of 
birth, and Sweden, the host country. Study IV was carried out to examine the prognosis 
of cervical cancer among women in Sweden with regard to immigrant status, cervical 
screening attendance and socioeconomic status, as measured by occupational class and 
education level. The methodological aspects will be discussed separately for the register-
based studies (Studies I, II and IV) and the qualitative study (Study III). 
 
7.2 METHODOLOGICAL CONSIDERATIONS 
 Sources of error in epidemiological studies (Studies I, II and IV) 7.2.1
Though epidemiological studies aim to provide accurate estimates, different types of 
errors may occur. Sources of error in epidemiological studies can be either random, or 
systematic. Random errors are related to problems with precision; systematic errors stem 
from issues such as selection bias, confounding and misclassification. Internal validity 
refers to the absence of systematic errors, and is the degree to which the results are correct 
for the group under study. External validity (generalisability) refers to extent to which the 
study’s results can be applied to people outside the study sample. The reliability of a study 
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refers to the degree to which the results can be replicated, and depends on both validity and 
precision.  
 
 Random error 7.2.2
Random error is when a value of the sample measurement deviates from that of the true 
population value by chance alone. Random error cannot be completely eliminated in 
epidemiological studies, as only a sample of the reference population is used. Random 
error causes inaccurate measures of association. The best way to reduce random error is 
to increase the size of the study sample. High precision may also eliminate random 
errors. To assess whether the results of the register-based studies could be due to 
chance, the likelihood that the observed result was a due to sampling variability was 
determined using statistical tests. In epidemiological research, the use of statistical 
methods in assessing risk estimates in combination with the calculation of 95% CIs 
aims to show the degree of precision and the risk of random error. In Studies I, II and 
IV 95% CIs and p-values were used to show the level of precision of the estimates. 
Results where the 95% CI included 1, or where p-values were more than 0.05, were 
considered to have occurred by chance. In other words, there is a 95% probability that 
the result was due to chance. It should be noted that narrow CIs and very low p-values 
show higher precision. The register-based studies in this thesis (Studies I, II and IV) 
were population-based. These registers cover the entire population in Sweden, 
including the legal immigrant population, which is relatively large. Therefore the 
sample size could be considered reasonably large, and capable of rendering reliable 
estimates. However, some of the subgroup analyses within the study samples were 
based on small numbers, and therefore involved a larger statistical uncertainty. 
 
In Study I the change in the risk of cervical cancer was evaluated by follow-up time in 
the host country in stratified analyses. Because the 10-year follow-up time in Study I 
was fairly short, few cancers were detected, making it difficult to interpret the results 
estimated for this stratum. In addition, power problems were encountered as immigrants 
from most low- and medium-resource countries were young, and did not reach an age at 
which cancer usually presents itself. The power problems were especially present when 
studying the effect of age at immigration and follow-up time. 
  
 68 
 
In Study II there was limited power to study the hypothesis of adherence to 
recommended screening intervals and risk of cervical cancer for every country of birth 
considered. Left truncation led to a further loss of study power in the analyses. In Study 
II, follow-up time was from 1993-2005 because of incomplete data on cervical 
screening attendance, whereas in Study I it was from 1968-2004. Left truncation occurs 
when individuals who have already passed the milestone, in this case the diagnosis of 
cervical cancer, at the time of study recruitment (229) are not included in the study. The 
RR of cervical cancer was therefore estimated, controlling for screening adherence, 
both for all immigrants and for selected groups of immigrants in Study II, where the 
power was reasonable. Moreover, the lower RR of cervical cancer among all 
immigrants, compared to Swedish-born women contrasted with a previous report (230). 
This left truncation may therefore have led to over-representation of women with a low 
risk of cervical cancer.  
 
In Study IV the countries of birth were partially collapsed into larger regions to meet the 
requirements of statistical power calculations. Using statistical power in STATA, the 
power calculations showed that it at least 294 women were needed to detect a HR of 0.7 
with 80% power. However, even if efforts were made to keep the same categorisation 
that was used in Studies I and II, some modification was needed in order to create 
groups that were large enough to allow for meaningful interpretations of any 
differences (or lack thereof). All groups of immigrant women had at least 110 cervical 
cancer cases or more, except for immigrant women from Africa, among whom only 15 
cases were observed. Therefore, the assessment of 10-year survival and HRs with 95% 
CIs for cervical cancer among Swedish-born and immigrant women in Sweden in 1960-
2005 involved larger statistical uncertainty. 
 
 Systematic error 7.2.3
Systematic error arises when results differ in a systematic manner from the true values 
(204). The main possible sources of systematic error are selection bias, information bias 
and confounding (203).  
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Selection bias 
If there is a systematic difference between the characteristics of individuals in a study sample 
and those who are not, and if those characteristics are related to either the exposure, or 
the outcome under study, selection bias has occurred. Selection bias leads to a distortion 
of the effect as a consequence of the way participants are included in study samples 
(204).  
 
The “healthy migrant effect” 
Because the focus of this thesis was to study immigrant status in relation to cervical cancer, 
adherence to cervical screening and cervical cancer prognosis (risk of mortality), the women 
included were selected by their immigrant status and country of birth. Migrant populations 
are a self-selected sample of the population of their country of birth. Very often they 
come from quite limited geographical areas. Moreover, those with poor health in the 
labour immigrant group are commonly underrepresented, introducing an inherent 
selection bias, a “healthy migrant effect” similar to the “healthy worker effect” (1). For 
example, immigrants from the former Yugoslavia that moved to Sweden in 1960s and 
1970s were often recruited as workers, whereas immigrants from Czechoslovakia and 
Poland were often highly educated refugees and arrived in Sweden during the 1980s 
(231). The “healthy migrant effect” may be a result of the fact that seeking a new life 
overseas infers a population that has resources and is active (1). Nevertheless, there is 
no evidence for positive selection bias in the studies in this thesis, which would be the 
case if cancer-prone individuals or cancer patients preferentially immigrated, or were 
preferentially allowed immigrant status. However, it is plausible that a “healthy migrant 
effect” has occurred. 
 
Information bias 
Measurement errors in one variable, i.e. exposure or disease can cause bias in 
estimating an effect which is called information bias. Misclassification of an exposure is 
sometimes non-differential with respect to outcome status, i.e. equally present whether the 
subject is a case or not. Non-differential misclassification tends to lead to an 
underestimation of the true strength of the relationship. Differential misclassification 
occurs when the misclassification is unequally distributed with respect to outcome. This 
will either exaggerate or underestimate the effect, and the direction may sometimes be 
difficult to predict. Information on the exposures and outcomes used in Studies I, II and IV 
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was taken from national registers. A quality assessment of these registers has been 
presented in this thesis.  
 
The classification of cervical cancer as the outcome in Study I was not a notable concern. 
The completeness of the Swedish Cancer Register in 1984 showed that reporting of 
cancer cases was more than 98% complete, which made it possible to identify almost 
all incident cases of cervical cancer. Cancers recorded in the Swedish Cancer Register 
are classified by ICD code (232). In 2000, 100% of the registered cervical cancer cases 
had been verified by either cytology or histology (233).  
 
In Study IV the outcome was death due to cervical cancer. As from 1995, the Cause of 
Death Register has included a correct underlying cause of death in 77% of all deaths, and 
in 90% of deaths from malignant tumours (234). However, in Study IV the finding of 
improved prognosis among non-Nordic women may partly be attributable to an 
underestimation of deaths in the Cause of Death Register for these women, i.e. a woman 
may return to her country of birth after cancer diagnosis and in the event of death she will 
not be registered as a deceased non-Nordic immigrant in the Swedish register, although 
the Nordic countries have coordinated their population changes since 1969 (201). 
Women who die outside Sweden and are registered as Swedish residents will have their 
death recorded in Sweden, though the cause of death will not always be registered. In this 
thesis, these women were censored because of the possibility that they died of other 
causes, but in the previous scenario they were assumed to be alive until the end of follow-
up. However, the magnitude of this potential problem is expected to be very small. 
According to the Cause of Death Register, in 2007 0.8% of registered deaths among 
women who died outside Sweden had an unknown cause of death (235).  
 
When a woman was classified as an immigrant in Studies I, II and IV, the exposure 
information was based both on country of birth and immigrant status from the TPR and 
Migration Register, respectively. The TPR only includes immigrants that are legal 
residents and have a PIN. The fact that immigrant and emigrant registration does not 
necessarily cover every migrant, such as those who stay less than 1 year (236), refugees 
who do not yet have their residence permit (72), and immigrants from Nordic countries 
who do not need work permits or immigration documents (72), inaccuracies in person-
year calculations are unavoidable. However, most probably this did not affect the results 
 71 
 
significantly, since the desire among immigrants to become registered is strong as it 
comes with the right to collect benefits (237). Furthermore, even though 65% of all 
asylum seekers were granted a residence permit in 1996-1997 (because of the war in the 
Balkans), this number fell to 30% in 2001. In was estimated that 11 235 women sought 
asylum in 2003 (238). The estimated figure on short-term immigrants was 41 000 
individuals (men and women) in 2004, but according to Statistics Sweden this estimation 
should be taken with caution. The under-coverage should be negligible, and if it effects 
the estimations in Studies I, II and IV in any direction, it overestimates them. 
 
Register-based follow-up of immigrants may be a concern if they emigrate without 
reporting this to the authorities, leading to over-coverage in the population statistics. 
The continuous follow-up of individuals who emigrate without any censor events, i.e., 
cancer (Studies I and II) or death (Study IV), accrues person-time to the cohort, and 
thus underestimates the incidence of cancer or prognosis. A report from Statistics 
Sweden in 1999 estimated a 4-8% over-coverage of non-Nordic immigrants in the TPR, 
although, as previously mentioned, the Nordic countries have coordinated their 
population changes since 1969 (201). Moreover, because of the high-quality health care 
system (123) and health insurance in Sweden, a woman with cancer might prefer to 
return to Sweden if she is still a registered legal immigrant in Sweden. Therefore, the 
over-coverage is an unlikely explanation for the findings in Studies I and II.  
 
In Studies II and IV, data on screening attendance in 1993-2005 was used, but during this 
period screening registration was not entirely complete: screening information was 
lacking from two out of 30 pathological laboratories in Sweden. All women were 
assumed to be non-attenders at cohort entry. However, if they had any record of 
cervical screening at cohort entry, or up to 6 years before that, they were assumed to be 
attenders at cohort entry. Non-differential misclassification may have occurred if we 
assumed women were non-attenders due to the lack of information from these two 
pathological laboratories, when they were in fact attenders. From 1995 onwards, the 
NCSR covered all of Sweden. Thus, the inclusion of data from 1993 and 1994 may 
underestimate the results in Study II, where the main exposure was cervical screening 
attendance, but it probably did not affect our results to any great extent. 
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Household occupational class and women’s education level were utilised as indicators of 
socioeconomic status in Study IV. The information on household occupational class was 
retrieved from the Swedish Censuses. The response rate in both the 1960 and 1980 
Censuses was 99%, whereas in the 1990 Census it was 98%, which makes the data 
reliable. The information on education level was based on information from the National 
Swedish Education Register, and it is estimated that the proportion of Swedish-born 
individuals with an unknown education level is less than 1%, while among immigrants it 
is 7%.  
 
Individuals who have never attended school are included in the group with unknown 
education level (missing information) both among Swedish-born individuals and 
immigrants in the National Swedish Education Register. Investigation of the individuals 
with missing information shows that if they had been accurately classified they would 
most likely have been assigned a low education level (9 years of schooling or less). 
Furthermore, 87% of Swedish-born women and 70% of immigrant women have an 
education level that is correctly classified. According to the population and welfare 
statistics in Sweden there is an overestimation of individuals with a low education level 
and underestimation of those with a high education level among both Swedish-born and 
immigrant women (217).  
 
An aspect specific to cervical cancer epidemiology is that incidence and mortality rates 
are calculated using the entire female population as the ‘population at risk’. However, 
women who have had a total hysterectomy for reasons other than cervical cancer are 
not at risk for the disease (21). Hysterectomy is estimated at 2.1 per 1000 female 
residents in Sweden (239). A slight underestimation of the IRs might therefore have 
taken place. 
 
Confounding 
Confounding occurs when another exposure (or risk factor) exists in the study 
population and is associated with both the disease and the exposure being studied, but is 
not part of the causal pathway between the exposure and the outcome. Therefore, when 
the effects of two exposures (risk factors) have not been separated, it can lead to the 
incorrect conclusion that the effect is due to one rather than the other variable.  
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Confounding can be neutralised at the design phase of a research project (for example, 
by restriction) and/or at the analysis phase (for example through stratification and 
multivariate statistical modelling), as long as all the confounders have been measured 
properly. Stratification includes the measurement of the strength of associations in 
well-defined and homogeneous categories (strata) of the confounding variable (for 
example, age groups). However, a large study sample is needed to perform 
stratification, and stratification does not allow to control for many factors 
simultaneously. Multivariate statistical modelling is required to estimate the strength of 
associations while controlling for several confounding variables simultaneously. In the 
analysis phase of Studies I, II and IV confounding was dealt with by adjustment for 
known variables in regression models. We adjusted for attained age, calendar time and 
county of residence at diagnosis (Studies I, II and IV). 
 
One of the limitations of the register-based data used in Studies I, II and IV is the lack 
of information on possible confounders, which may have introduced residual 
confounding in our studies. The potential impact of confounding factors depends on 
their occurrence in the study population, and the strength of their association with the 
outcome. The potential confounders smoking, early age at first sexual intercourse, high 
lifetime number of sexual partners, use of oral contraceptives, high parity, other STIs 
(240,241), and marital status (136-138) may affect the association between immigrant 
status and risk of cervical cancer or immigrant status and cervical screening attendance.  
 
Clinical stage at presentation may act as a confounder in cases of differences in prognosis 
between the immigrant and Swedish-born women. Unfortunately, in Study IV information 
on clinical stage at diagnosis or treatment was not available, which may have affected the 
relationship between invasive cervical cancer diagnosis and prognosis. As only small 
differences were found in the risk of cervical cancer mortality between Swedish-born and 
immigrant women (with an advantage for the latter group), access to this information 
would most likely not have changed the study results to a large extent. Based on 
information from previous studies, it is known that history of cervical screening 
attendance is a good proxy for clinical stage at diagnosis (190,221), and adjusting for 
screening history in the present study did not change the main result. Adjustment for 
calendar time helped account for gross changes in cancer treatment over time, but it did 
not provide insight into the equality or inequality of treatment according to education 
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level. However, adjustment for calendar time in the analyses from 1993-2005 did not 
change the results substantially, indicating that no major changes occurred in cancer 
treatment during this time period. Furthermore, since it was postulated that follow-up 
after cervical cancer diagnosis could vary by county, we tested for interaction between 
history of cervical screening attendance and county of residence at diagnosis; the result 
showed no significant difference. Moreover, the prevalence of co-morbidities was not 
investigated in Study IV. Although nutrition and psychosocial supports are known to vary 
across socioeconomic groups, there is less evidence to determine the extent to which 
these variables account for differences in cervical cancer prognosis (242). 
 
Effect modification and interaction 
Effect modification refers to the effect of a certain exposure on an outcome which is not 
the same depending on the value of a third variable. Therefore, the measure of effect 
changes over the value of this third variable. When effect modification is detected, it 
needs to be managed, either by stratifying the analyses by this third variable, or by 
conducting an interaction analysis where the variation introduced by this third variable is 
considered. In Study I p-values were calculated for the interaction between country of 
birth, follow-up time and age at immigration, respectively, in the regression model. 
Further stratifications for follow-up time and age at immigration were done for the 
immigrants from Nordic countries and the Baltic States, where there was reasonable 
power in the data. In Study II, stratification by age at immigration was done to assess 
immigrant women’s cervical screening attendance. In Study IV, the effect of education 
level on the prognosis of immigrant women by age at immigration was assessed, but the 
affect was not altered. 
 
 Other methodological considerations 7.2.4
Reverse causality was tested by excluding cervical cancer cases from the study sample in 
Studies I and II to address the concern of prevalent cancer among immigrant women 
arriving in the host country, which would lead to biased estimates of cervical cancer 
incidence. To allay this concern the analyses were repeated after excluding the first 2 
years of follow-up. Since this did not notably change the results, all the available data 
were used in the analyses. 
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In Study II, all Pap smears taken within 6 months of a cervical cancer diagnosis were 
excluded, since screening attendance was different from diagnostic screening. Neither 
were these Pap smears counted as screening history, as they would not have prevented 
invasive cancer through detection and removal of a pre-invasive lesion, as the invasive 
cancer was already present. Out of a total of 10 948 015 Pap smears, 9530 were 
excluded (0.09%).  
 
 External validity 7.2.5
External validity or generalisability refers to how relevant the results for a given study sample 
are to the general population. If the results are not trustworthy within a study, i.e., if the 
internal validity is not good, it is worthless to consider whether they can be applied to the 
general population. In addition, in order to create a fair sample of the source population, 
researchers must select a representative sample of that population.  
 
The possibility of constructing a sample of immigrant women that are representative of the 
population of their country of birth is debateable. Although the “healthy migrant effect” may 
partially explain differences in the incidence of cervical cancer among our immigrant women 
compared to that among women in their countries of birth, it is likely that less selection 
occurs among immigrants from countries that are geographically close to the host country, 
and more selection occurs among immigrant from countries that are farther away. The 
register-based studies in this thesis are population-based cohort studies based on Swedish 
registers. Therefore the results should be generalisable to the legal resident immigrant 
women in Sweden. In Study II the study sample was taken from women attending cervical 
screening, both opportunistic and organised, in Sweden, and therefore the results should be 
generalisable to a large part of the female population in Sweden. 
 
 Rigor and trustworthiness (Study III) 7.2.6
Concepts used in qualitative research to describe trustworthiness of the research are 
credibility, dependability and transferability as opposed to concepts mostly used in 
quantitative research such as validity, reliability and generalisability (225). In Study III 
credibility was increased through triangulation, reflexivity and peer debriefing. 
Common standard practice was also used for qualitative studies, such as supervision, 
training, tape recording and transcription. Credibility refers to confidence in how well 
the data and the processes of analysis address the research objectives under study. 
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Credibility concerns issues such as context, participants, and different approaches to 
data collection. Furthermore, variance of interviewees and observers’ perspectives of 
the phenomenon under study contributes to richer data (225).  
 
Another important aspect of trustworthiness is dependability, which refers to an 
assessment of the quality of the processes of data collection, data analysis, and theory 
generation (243). Graneheim et al argues that it is possible within a research team to 
address dependability by having an open dialogue about “the degree to which data 
change over time and alterations made in the researcher’s decisions during the analysis 
process” (225).   
 
Study design 
FGD is a data collection technique that relies on the dynamic of group interactions to 
stimulate the discussion. Through these interactions the health-related beliefs and 
behaviours of the women under study contribute to produce rich and detailed data from 
individual perspectives that could not have been obtained using other methodological 
strategies (228,244).  
 
FGD participants and sampling 
FGDs may consist of 4-12 participants. With fewer participants a research topic may be 
discussed more in depth, and with more participants it may bring a greater variety of 
views (228). In Study III each focus group consisted of three to seven participants. We 
experienced sampling difficulties, especially among Norwegian women, and some 
women who expressed interest in participating were hindered by a variety of practical 
and logistical obstacles inherent to their life situations, which has also been reported in 
previous research (245). Therefore we cannot be certain that saturation was reached (i.e., 
that no more new information was surfacing during the FGDs) for Norwegian women. 
Difficulties in recruiting hard-to-reach populations, such as minorities, pose challenges in 
accessing and gaining the trust of potential participants (246). The FGDs in Study III 
were held at Karolinska Institutet, which was comfortable and accessible to the 
participants (247). Furthermore, participating women expressed that they saw the 
invitation to participate in the FGD at Karolinska Institutet to be of significant value.  
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Reflexivity 
As reflexivity, i.e., the influence of the researcher on the setting or individuals studied, 
can threaten credibility, the goal in a qualitative study is not to eliminate this influence, 
but rather to understand it and use it productively (248). The moderators were trained in 
subjects related to cervical cancer and cervical screening attendance among immigrant 
women in Sweden, and in how to handle different situations that could arise during 
FGDs. Furthermore, the actions taken by the assistant who attended the FGDs 
(previously described in detail in Material and Methods) were meant to enhance the 
study’s credibility and trustworthiness. 
 
The FGDs began with a 10-20-minute presentation by the moderator of the study and the 
guiding principles of the discussion. Participants were also asked to introduce 
themselves. The duration of discussion preceding the FGD was chosen as participants’ 
awareness of the situation was likely reduced after this period of time.  
 
Another way the undesirable consequences of reflexivity were minimised was to avoid 
leading questions by discussing the FGD guide with different researchers outside the 
research team and the moderators. Furthermore, the multidisciplinary nature of the 
research team brought varied and practical expertise, as is recommended in studies 
among immigrants (249). The research team that participated in the design, data 
collection and analysis were well versed in conducting qualitative studies. The team 
approach was also used for data analysis in order to strengthen the trustworthiness of the 
categorisation and interpretations of the findings. According to Krueger (228), analysis 
benefits from multiple insights and perspectives, such as those from co-researchers. In 
Study III, three of the six research team members had direct experience in the area of 
investigation, took an active part in data collection, and were also helpful in the 
interpreting of findings. Therefore I believe that this approach strengthened the 
trustworthiness of the categorisation and interpretations.  
 
Triangulation and peer debriefing 
Triangulation and peer debriefing were also used. Triangulation is a technique in which 
the researcher uses several methods and perspectives of different people or groups to 
produce comprehensive findings (250). Triangulation is based on the idea that no single 
method can adequately answer the research problem and that by using various methods 
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of data collection and analysis, different aspects of empirical reality are revealed (251). 
Method triangulation, investigator triangulation and triangulation of data sources are 
common triangulation methods (252,253).  
 
In Study III, data was collected from multiple sources using immigrant groups from 
two countries, with two age groups defined within each immigrant group, thus 
achieving triangulation of data sources. Investigator triangulation was also used by 
using two native speakers, one Danish speaker and one Norwegian speaker, as 
moderators, with a two-fold purpose. One purpose was to reach a varied sample by 
encouraging women who were hesitant to participate due to language problems to 
participate. The other reason was to encourage richer exchanges by facilitating discussion 
through the opportunity for the participants to discuss in their own language if they so 
wished for clarity of thought. I believe the triangulation methods have strengthened the 
credibility of the study. Peer debriefing of both researchers and professional colleagues 
was carried out, during which information on what was emerging from the study was 
shared, and feedback and valuable comments were received (250,254).  
 
Transferability 
Transferability is also an important aspect regarding trustworthiness; it refers to how 
applicable the results may be to other contexts. Graneheim et al argued that the researcher 
can facilitate and suggest transferability, but that it is for the reader to judge whether it is 
transferable or not (225). It is important to give as thorough a description of the context 
of the study as possible. The description of how participants were selected, their 
characteristics, and how data was collected and analysed must be clear to facilitate the 
transferability of research findings to other contexts. However, the purpose of this study 
was not to collect data that can be used to make general statements, but to explore 
different aspects of the research topic. Although the credibility of generalisations from 
a qualitative study is not as good as that from a quantitative study, this does not mean 
that no generalisation can be made beyond the setting or informants in qualitative 
studies. It is important to be aware that qualitative studies often have what is called face 
generalisability: “there is no obvious reason not to believe that the results apply more 
generally” (255). The FGDs were held with a limited number of women in one urban 
area. The results can thus not be generalised to the larger Danish and Norwegian 
immigrant population in Sweden in our view. However, obtaining a more profound 
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understanding of how immigrant women reason about their cervical screening attendance 
requires a qualitative approach. 
 
7.3 DISCUSSION OF MAIN FINDINGS 
Populations of immigrant women comprise a substantial number of individuals who 
have undergone a change in their environment, both socio-culturally and physically. 
Because of great variation in the prevalence of HPV infection and other risk factors for 
cervical cancer worldwide, immigrant studies may help further the understanding of the 
aetiology, and improve the prevention of cervical cancer. One of the main intentions of 
this thesis was to infer changes in the risk of cervical cancer among immigrant women 
given the relative aetiological importance of environmental factors versus inherited 
predisposition.  
 
The degree of convergence between immigrant women and the population ASRs of 
Swedish-born women, and divergence between the rates in immigrant women and those 
in the country of birth, were investigated in this thesis. This may indicate that the ASRs 
for most low- and medium-resource countries are underestimated. Additionally, results 
are presented in this thesis for immigrant groups that originated from countries with no 
cancer registration, such as Turkey, Iraq, Iran, Lebanon, Chile, Greece, Romania and 
Hungary (8). These results may serve as estimates of the cancer rates in their countries 
of birth, but with debatable accuracy, since this assumes that no large selection has taken 
place. Furthermore, it must be remembered that figures presented by Globocan 2002 
measure incidence long after the implementation of cervical screening in many European 
countries, while data in this thesis is based on a long follow-up time. The time period 
covered in this thesis comprises both ends of the spectrum in Sweden: the initial phase, 
where the incidence of cervical cancer was still high and cervical screening had just been 
introduced, and the long phase of low cancer incidence after the introduction of cervical 
screening. This may partially explain the higher ASR estimates presented in this thesis.  
 
The variable immigrant status, although highly reproducible and subject to little 
misclassification, is a proxy for a host of unmeasured exposures and genetic 
predispositions. An association was shown between immigrant status and the risk of 
cervical cancer, and the association was significantly modified by follow-up time and age 
at immigration. The risk of cervical cancer decreased by follow-up time for most 
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immigrant groups, and the older women were when they immigrated to Sweden, the 
higher their risk of cervical cancer. In order to evaluate the change in the risk of cervical 
cancer among immigrant groups in the host country, 10 years was assumed to be 
sufficient to affect the risk of cervical cancer. The pattern of changes in risk of cervical 
cancer experienced by immigrants may suggest that sustained exposure is needed 
before the risk of cervical cancer is altered, or that the agent is only important with 
respect to exposures early in life. It has been postulated that the first 2 decades of life 
are what establish the risk of cancer development later in life. Therefore, if an 
immigrant woman enters Sweden in her 20s it may already be too late to influence her 
environmentally imprinted cancer development programme (129).  
 
The estimation of risk of cervical cancer by follow-up time in the new host country and 
age at immigration used in this thesis is one of two possible approaches to investigate 
the rate of change of risk in immigrants, namely the study of risk in relation to age at 
immigration/duration of residence and the comparison of risk in immigrants and their 
offspring. However, as age itself is such a strong determinant of the risk of cervical 
cancer, and is an essential factor in any analysis, there is no variability left in follow-up 
time after controlling for age at immigration, or vice versa. Thus, these two variables 
are closely inter-related, which implies difficulties in distinguishing the effects of one 
variable from that of the other. A pragmatic solution was adopted in this thesis: to 
examine each variable in turn (age/follow-up time or age/age at immigration) to see 
which provided the most plausible pattern of change in risk, bearing in mind that 
follow-up time and age at immigration are inevitably mutually confounded (1). 
 
The risk of cervical cancer was heavily reduced among immigrant women who adhered 
to the recommended screening intervals. However, adherent Norwegian and Baltic 
immigrant women showed IRs as high as 10 and 17 per 100 000. This may indicate a 
high prevalence of risk factors that are not fully addressed by cervical screening, such 
as changes in lifestyle factors and/or the detection of prevalent cancers through the 
screening programme. The influence of environmental factors on cancer risk and 
immigration embraces not only the abrupt change in physical surroundings, but also 
comprises elements of lifestyle. Examples of lifestyle factors are childbearing patterns, 
alcohol and tobacco consumption, and sexual behaviour (1).  
 
 81 
 
The sexual behaviour of immigrant women and their partners in the host country is one 
of the lifestyle factors that needs to be considered in this thesis. The public health 
interest in sexual behaviour is due to the association between reproductive health and 
STIs such as HPV, which is a causal factor in cervical cancer development. Although 
immigrants to countries with a liberal sexual attitudes such as Sweden clearly have the 
same potential to adopt these liberal attitudes as the Swedish-born population, 
immigrants may be more or less inclined to retain the culturally-defined sexual 
behaviour of their country of birth. The sexual attitudes in Sweden and other Nordic 
countries are known to be relatively liberal and open (256). But although the attitude 
toward sexual matters is a notably open feature of Swedish society, there are different 
degrees of openness and it is mainly the biological side of sexuality that is openly 
discussed (257). 
 
The Swedish tradition of a supportive approach towards adolescent sexual relations, 
including the existence of a network of youth health clinics, needs to be evaluated in 
view of the changing epidemiology of sexual health in Sweden. The increase in the 
incidence of STIs such as chlamydia and gonorrhoea, and the spread of HPV and 
herpes simplex virus type 2, in combination with the decrease in condom sales, might 
be an indication that the practice of safe sex is decreasing (258).  
A population-based, cross-sectional study reported a median age at first sexual 
intercourse of 16 years for women in Sweden, Denmark, Norway and Iceland, and 
noted that many women in these countries have had more than 10 sexual partners in 
their lifetime (259). This is of significance as both early age at first sexual intercourse 
and high lifetime number of sexual partners are considered risk factors for cervical 
cancer. The relatively high sexual activity among women living in the Nordic countries 
may partly explain the comparatively high incidence of cervical cancer observed among 
Nordic immigrants in Sweden, as presented in the results from Study I. The risk of 
cervical cancer has been reported to be high in Denmark (260,261); this has also been 
shown to be the case among immigrant women from Denmark in Sweden in other 
studies (127,128). Sexual behaviour after immigration has been suggested to play an 
important role in the risk of cervical cancer. In addition, differences in the prevalence 
of HPV infection between immigrant women and the population of the host country 
may be influenced by sexual behaviour (129). The prevalence of HPV among women 
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with normal cervical cytology in Denmark is around three times higher than among 
women in Sweden (130). 
 
Immigrant status has been linked to later age at first sexual intercourse (262-265), lower 
number of sexual partners, and lower rates of contraceptive use (266,267) among 
Hispanics in the United States. Variations in age at first sexual intercourse by immigrant 
status are substantial, and the nature of these differences varies by country according to 
the culture and values of the particular minority or immigrant group (265). The age-
specific IRs (Study II) presented in Figure 2 increased and peaked at an older age (5-10 
years later) among immigrant non-attenders compared to Swedish-born non-attenders. 
This may indicate that the first sexual intercourse is occurring later among immigrant 
women than among Swedish-born women. HPV infection is essential in cervical cancer 
development. The effect of risk factors such as age at first sexual intercourse and 
lifetime number of sexual partners, is mediated via exposure to HPV or by affecting 
susceptibility to the carcinogenic effects of HPV (268). It has been shown that the high 
prevalence of HPV infection among immigrant women residing in Italy (132) correlates 
very well with the risk of invasive cervical cancer in these women. Crocetti et al (146) 
recently evaluated the risk of invasive and in situ cervical cancer, during the period 
2000-2004 among immigrant women aged 25-59 living in central Italy. The incidence 
of invasive cervical cancer among women born in Central and South America and the 
Caribbean (60.5 per 100 000) and among women born in Central and Eastern Europe 
(38.3 per 100 000) was statistically and significantly higher than that of Italian-born 
women (33). 
 
The high HPV prevalence and cervical cancer incidence in Africa compared to Eastern 
African immigrants in Sweden, who had an 80% decreased RR compared to Swedish-
born women, needs further investigation. One study found no significant difference 
among African immigrants in France compared to French-born women (139). In 
another study, cervical cancer mortality was observed to be 60% lower among Eastern 
African immigrants in England and Wales compared to that in the English- and Wales-
born population (140). In both these studies (139,140) it was suggested that the results 
may be due to the relatively higher socioeconomic status of these African immigrants. 
The variation in sensitivity and specificity of HPV testing methods may underlie some 
of the variability in HPV prevalence from different studies, but it is also worth 
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considering possible differences in surveillance and detection. Another plausible 
explanation is that this might indicate a larger selection mechanism (the healthy 
migrant effect). 
 
Tobacco use has been shown to be associated with geographical variations in lung 
cancer incidence (148), and has also been shown to increase the risk of cervical cancer 
(65). A study on the risk of lung cancer among immigrants to Sweden reported that 
ASRs (World) from 1993-2008 for lung cancer by histology among women in Sweden 
were 14.3 per 100 000 and among all immigrants combined 13.4 per 100 000. 
However, there was a large variation, with Danish (23.3), Norwegian (19.5) and 
Finnish (14.5) immigrant women having the highest IRs of lung cancer, and Asian and 
Arab women having the lowest IR (5.8). Consequently, smoking behaviour in the host 
country is a likely explanation for the preservation of IRs of lung cancer in the country 
of birth. It has been reported that immigrant women from other European countries in 
Sweden smoke more than Swedish-born women, while those who are born outside 
Europe smoke the least (269,270). 
 
The higher risk of cervical cancer found among women who were older at immigration 
may be due to persistent HPV infection, or the presence of precancerous lesions before 
immigration, in combination with a lower adherence to cervical screening. In addition, 
women are not invited to organised screening after 60 years of age in Sweden. 
 
In this thesis an excess risk of cervical cancer mortality was observed among both 
Swedish-born and immigrant women with low education level, independent of history of 
cervical screening attendance. One study in Sweden showed statistically significantly 
higher survival rates for the highest group of socioeconomic status (271). It has also 
recently been shown that the odds of cervical cancer morbidity and mortality in Sweden 
are higher among women residing in deprived neighbourhoods than among women living 
in wealthy neighbourhoods. Adjustment for individual-level sociodemographic variables 
and comorbidities did not alter this difference (272). The pronounced hierarchy among 
different immigrant groups and Swedish-born women is a striking feature in Sweden 
that exists both in the labour market and in housing. This is further characterized by the 
distinct multi-ethnic character of all immigrant-dense neighbourhoods. In Sweden, 
immigrants are often young adults, and households comprised of young adults are 
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overrepresented in rental housing. Demography as well as income could be factors that 
explain immigrants’ positions in the housing market. Although housing location might 
be the result of immigrants’ preferences, their labour market position is not (273). 
However, neither the causal pathways between neighbourhood socioeconomic 
deprivation and poor health outcomes nor socioeconomic status and prognosis are fully 
understood. 
 
In summary, there is a close association between an individual’s lifetime exposure to 
various risk factors and carcinogenesis. Other important factors in cancer development 
and the causal roles of exposures in the country of birth are represented by the time 
before and after immigration, as well as the influence of social factors in the country of 
birth (274-277). However, this kind of information is rarely available, and this thesis is 
no exception. A main reason for the diversity of cancer risk with duration of residence in 
the host country, which in this thesis refers to the effect of follow-up time, is that 
exposure to risk factors and adaptation to changing environments evolve over time. 
Cancer risk among immigrants can be expected to converge towards the rates of the 
population in the host country over time and across generations, which can be seen as a 
consequence of a simultaneous decrease among immigrants with high cancer incidence 
and increase in those with a formerly low cancer incidence (274-277). 
 
The persistence of cervical cancer risk across generations, i.e., among first- and second-
generation immigrant women, was not investigated in this thesis. However, a Swedish 
study has shown that both risk of cervical cancer and cervical cancer mortality were 
fairly unchanged in second-generation compared to first-generation immigrant women. 
The authors (128) suggested that the risk factors and protective factors of cervical 
cancer, which were mainly behavioural aspects, were retained after immigration and 
across generations and/or that it could represent an aetiological factor by familial 
aggregation.  
 
Despite the many similarities between Denmark, Norway and Sweden with regard to the 
way of life, history, language and social structure, including the existence of an organised 
cervical screening programme (278,279), immigration to Sweden per se seemed to 
influence our participating Danish and Norwegian immigrant women not to attend to 
cervical screening according to the recommendations of the Swedish National Board of 
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Health and Welfare. Consistent with previous research, competing needs have been 
shown to be major obstacles to cervical screening attendance among immigrant women 
(280). However, the competing needs evoked by immigrant women in the United States 
were essential needs, such as food, shelter and clothing (280). The Danish and 
Norwegian immigrant women in our study discussed specifically how their energy and 
focus were consumed by the change of environment, attempts to learn how different 
societal systems worked in the new country, and to their resettlement efforts, all of 
which are related to competing needs due to the immigration. This may indicate that the 
process of transitioning to life in a new country can be difficult and stressful for 
immigrant women even if the new host country is a neighbouring country with many 
similarities. Danish and Norwegian immigrant women who took part in this qualitative 
study revealed views that can be summarised into one main theme: “Women have a 
comprehensive rationale for postponing cervical screening, yet do not view themselves 
as non-attenders”. This view was apparent even when the delay had been up to a 
decade. The main finding indicates that postponement of cervical screening attendance 
was based on the women’s rationale, which was partially explained by factors related to 
immigration, but was also influenced by other aspects, such as previous experiences, 
psychological and individual factors, childbearing-related factors, social support and 
social network, and risk perception. The women’s reasoning thereby revealed no active 
stance against attending cervical screening (defined as attendance according to the 
recommendations of the Swedish National Board of Health and Welfare). The women’s 
reasoning of postponement was rather due to a comprehensive rationale. 
 
While human papillomavirus vaccination will probably play a major role in the primary 
prevention of cervical cancer for young birth cohorts in the future, cervical screening will 
remain the principal strategy to prevent cervical cancer for many decades. The public 
health benefits of newly introduced HPV vaccines offer an opportunity to address 
cervical cancer disparities, but a substantial decrease in cervical cancer burden will only 
be attained if the new technology is also accepted and used by high-risk groups, 
including high-risk immigrant groups (161). If HPV vaccination was offered to younger 
birth cohorts of immigrant groups who do not participate in screening, it could have a 
long-lasting impact and reduce the risk of cervical cancer substantially in the future. 
For immigrant women who are beyond the age at which HPV vaccination is 
recommended or is effective, efforts to improve access to cervical screening should 
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continue, especially for immigrant groups with a high risk of cervical cancer. Overall, 
the results presented in this thesis demonstrate that immigrants in Sweden bring their 
own unique health characteristics with them. These characters may be quite different 
from those of the general Swedish population and are also likely to differ according to 
their country of birth. 
 
7.4 IMPLICATIONS OF FINDINGS 
Health care providers should be aware of immigrant women from regions where there is 
a high risk of cervical cancer. Clinicians who care for women who have immigrated from 
these regions should obtain a careful medical history to determine whether a Pap smear 
was performed prior to immigration, or after their arrival in Sweden, and should offer 
them an additional Pap smear unless their previous results were normal. Furthermore, 
clinicians should seize the opportunity to discuss cervical screening attendance with 
newly immigrated women, including where and how to get screened, which could be 
highly influential in their decision to attend cervical screening. 
 
Though the organised cervical screening programme in Sweden invites all women 23-60 
years of age, it would be justified to have a more prompt approach to screen older 
female immigrants at least once after their arrival in Sweden. Immigration at older ages 
seems to infer a higher risk of cervical cancer and should be considered an important 
barrier to cervical screening, which in turn infers a high risk of cervical cancer.  
 
A good cervical cancer prevention programme must determine the demands that will be 
placed on high-quality organised cervical screening in the future. This should include 
reaching women who are most in need of screening though targeted prevention and 
identification of risk factors and high-risk groups. In order to reduce cervical cancer 
mortality, the importance of increasing the coverage of cervical screening programmes 
among patients with low socioeconomic status, regardless of whether they are 
immigrant or Swedish-born women, should be emphasised in public health 
programmes.  
 
Despite a higher risk of cervical cancer among certain immigrant groups compared to 
others, and a lower degree of cervical screening attendance among immigrant women 
compared to Swedish-born women, cervical cancer prognosis is still 20% better among 
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non-Nordic immigrants, whereas no significant differences were observed among Nordic 
immigrants. This seems to indicate that as long as women diagnosed with cervical cancer 
have access to high-quality care and treatment, there is a chance for a good prognosis, 
regardless of their country of birth.  
 
7.5 CONCLUSIONS 
In Study I the incidence of cervical cancer among immigrant women was generally lower 
than that among women in their country of birth. However, immigrants from Finland, 
Denmark and Norway had considerably higher ASRs compared to women in their 
country of birth. Compared to Swedish-born women, the risks of cervical cancer among 
women from Northern Europe, Middle Africa and Central America were higher, while 
the opposite was true for women from Eastern Africa and South Central Asia. It was 
concluded that age at immigration and follow-up time were important effect modifiers for 
the risk of cervical cancer among immigrant women in Sweden; those who immigrated at 
an older age (≥50 years) had a higher risk than those who immigrated at a younger age 
(<30 years), and the risk of cervical cancer decreased in many groups of immigrant 
women after living 10 years in Sweden. The decreasing trend in the risk of cervical 
cancer by follow-up time also indicates that the immigrants benefit more from the 
cervical screening programme the longer they live in Sweden. However, the increasing 
trend among immigrants from the Baltic States and Western Asia indicates that exposure 
to risk factors for cervical cancer in Sweden has probably increased over time for these 
women. Therefore targeted prevention programmes should be recommended for high-risk 
immigrant women, specifically those who immigrate at older ages (≥50 years). 
 
In Study II the mean cervical screening attendance among Swedish-born women was 
higher than among immigrant women in Sweden, and there was a higher proportion of 
immigrants who did not attend cervical screening at all. Cervical screening attendance 
showed large variations between immigrant groups, and attendance was lowest among 
those who immigrated at older ages. The risk of cervical cancer increased at least five-
fold both among immigrant and Swedish-born non-attenders. After adjustment for 
cervical screening attendance, only two immigrant groups showed an excess RR for 
cervical cancer, namely women from Norway and the Baltic States. We therefore 
conclude that adherence to recommended screening intervals is very effective in 
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preventing cervical cancer, although other factors, e.g., socioeconomic status and risk 
factor prevalence, should also to be taken into consideration. In addition, immigration 
at older ages seems to be an important barrier to cervical screening attendance, which 
infers a high risk of cervical cancer. 
 
In Study III, the main theme generated from the data was “Women have a 
comprehensive rationale for postponing cervical screening, yet do not view themselves as 
non-attenders”. Investigation of women’s rationale for non-attendance after being invited 
to cervical screening revealed, amongst the factors discussed, some complex reasons 
related to immigration itself, including competing needs, organisational and structural 
factors and differences in mentality. The rationale used to postpone cervical screening, in 
combination with the fact that women do not consider themselves to be non-attenders, 
indicates that they have not actively taken a stance against cervical screening, and reveals 
an opportunity to motivate these women to attend. 
 
In Study IV certain immigrant groups had a higher risk of cervical cancer than Swedish-
born women, but their prognoses were rather equal. Prognosis of cervical cancer was 
better among non-Nordic immigrants than Swedish-born women, indicating their equal 
access to health care in Sweden. Both Swedish-born and immigrant women showed a 
three- to four-fold, non-differential excess risk of mortality among symptomatic cases, 
with or without a history of cervical screening attendance, compared to screening-
detected cases. An excess risk of cervical cancer mortality was observed among both 
Swedish-born and immigrant women with low education level, independent of history 
of cervical screening attendance. This was also the case for Swedish-born women with 
low manual household occupational class, women from households not in the labour 
force and women with missing information on occupational class. The findings 
emphasise the importance of increasing the coverage of cervical cancer prevention 
programmes such as cervical screening among high-risk groups and patients with low 
socioeconomic status, be they immigrant or Swedish-born women, to reduce cervical 
cancer mortality.  
 
7.6 FUTURE RESEARCH 
One important area that remains unclear is whether differences in sexual behaviour by 
country of birth are consistent across the age spectrum, and the extent to which age at 
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immigration has an impact on high-risk sexual behaviour. Future studies will benefit 
from assessing partnership-level characteristics in addition to individual-level high-risk 
sexual behaviour. The investigation of the risk of cervical cancer among immigrants by 
HPV variants and other environmental factors is another important area of future 
research. 
 
There is also a need for more research regarding women’s views about health and 
disease, and their knowledge about cervical cancer and its prevention, which may also 
influence cervical screening attendance. Future studies on the identification of possible 
lifestyle and clinical factors that may account for apparent advantages and disadvantages 
in prognosis of immigrant groups and how they influence cervical cancer prognosis may 
further shed light on the aetiology of cervical cancer. This knowledge may improve 
opportunities from a public health perspective to adopt broad-based interventions that 
could produce substantial health benefits for women.  
 
There is still little understanding of how social determinants are affected by immigrant 
status, or how social determinants operate in conjunction with immigrant status to 
influence cervical cancer survival in a country with universal access to health care. One 
reason may be that socioeconomic status is a culturally sensitive variable, and that the 
tools to measure socioeconomic status need to be further developed and improved. Thus 
a part of the research agenda for the future is to develop a greater understanding of the 
joint and separate functioning of social determinants and immigrant status in influencing 
the risk of cervical cancer and its prognosis.  
 
Findings are important for further research on cancer aetiology, policy development 
and health service planning. Improved health promotion and disease prevention 
strategies could be further investigated, including primary and secondary prevention 
programmes, to encourage use of available health services (e.g. cervical screening 
programmes and HPV vaccination programme) and to meet the health needs of 
immigrants. 
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Table A1. Definition of birth regions used in Paper I 
Country of birth, region or risk-region Country of birth 
Sweden(L) Swedish-born women 
Eastern Africa(H) 
Burundi, Djibouti, Eritrea, Ethiopia, Kenya, Madagascar, Malawi, Mauritius, Mozambique, Rwanda, Somalia, Tanzania, 
Uganda, Zambia, Zimbabwe, Seychelles 
Middle Africa(H) Angola, Cameroon, Chad, Congo, Congo Brazzaville,  
Northern Africa(M) Algeria, Egypt, Libya, Morocco, Sudan, Tunisia 
Other Low risk areas(L) Egypt, Tunisia 
Other Medium risk areas(M) Algeria, Libya, Morocco, Sudan 
Southern Africa(H) Botswana, Lesotho, Namibia, South African Republic 
Western Africa(H) 
Benin, Burkina Faso, Cape Verde, Cote d’Ivoire, The Gambia, Ghana, Guinea, Guinea- Bissau, Liberia, Mali, Mauritania, 
Nigeria, Senegal, Sierra Leone, Togo 
Caribbean(H) Barbados, Cuba, Dominican Republic, Haiti, Jamaica, Trinidad and Tobago, S.T Lucia, Dominica 
Central America(H) Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Grenada 
South America(H) Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, Guyana, Paraguay, Peru, Suriname, Uruguay, Venezuela 
Chile(H) Chile 
Other High risk areas(H) Argentina, Bolivia, Brazil, Colombia, Ecuador, Guyana, Paraguay, Peru, Suriname, Uruguay, Venezuela 
USA and Canada(L) United States of America, Canada  
Eastern Asia(L) China, Hong Kong, Taiwan, Japan, Korea Democratic Republic, Korea Republic, Mongolia 
Other Low risk areas(L) China, Hong Kong, Japan 
Other Medium risk areas(M) Taiwan, Korea Democratic Republic, Korea Republic, Mongolia 
South Eastern Asia(M) Cambodia, Indonesia, Lao, Malaysia, Myanmar, Philippines, Singapore, Thailand, Viet Nam 
Other Medium risk areas(M) Indonesia, Lao, Malaysia, Singapore, Thailand 
Other High risk areas(H) Cambodia, Myanmar, Philippines, Viet Nam 
South Central Asia(H)  
Afghanistan, Bangladesh, India, Iran Islamic Republic, Kazakhstan, Kyrgyzstan, Nepal, Pakistan, Sri Lanka, Tajikistan, 
Turkmenistan, Uzbekistan 
Iran(L) Iran 
Other Low risk areas(L) Afghanistan, Pakistan, Tajikistan 
Other Medium risk areas(M) Sri Lanka, Turkmenistan, Uzbekistan 
Other High risk areas(H) Bangladesh, India, , Kazakhstan, Kyrgyzstan, Nepal 
Western Asia(L) 
Armenia, Azerbaijan, Bahrain, Cyprus, Georgia, Iraq, Israel, Jordan, Kuwait, Lebanon, Qatar, Saudi Arabia, Syrian Arab 
Republic, Turkey, United Arab Emirates, Yemen, Palestine 
 Iraq(L) Iraq 
 Turkey(L) Turkey 
 Other Low risk areas(L) 
Azerbaijan, Bahrain, Israel, Jordan, Kuwait, Qatar, Saudi Arabia, Syrian Arab Republic, United Arab Emirates, Yemen, 
Palestine 
 Other Medium risk areas(M) Armenia, Cyprus, Georgia, Lebanon 
Central and Eastern Europe(M) 
Belarus, Bulgaria, Czech republic, Hungary, Moldova, Poland, Romania, Russian Federation, Slovakia, Ukraine, Soviet 
Union, Czechoslovakia,  
 Romania(H) Romania 
 Poland(M) Poland 
Other Medium risk areas(M) 
Belarus, Bulgaria, Czech republic, Hungary, Moldova, Russian Federation, Slovakia, Ukraine, Soviet Union, 
Czechoslovakia, 
Northern Europe (excl Sweden) (M) Denmark, Estonia, Finland, Iceland, Ireland, Latvia, Lithuania, Norway, Sweden, United Kingdom 
Denmark(M) Denmark 
Estonia, Lithuania, Latvia(M) Estonia, Lithuania, Latvia 
Finland(L) Finland 
 Norway(M) Norway 
 Iceland, Ireland, UK(L) Iceland, Ireland, United Kingdom 
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Country of birth, region or risk-region Country of birth 
Southern Europe(M) 
Albania, Bosnia Herzegovina, Croatia, Greece, Italy, Macedonia, Malta, Portugal, Slovenia, Spain, Yugoslavia 
 Greece, Italy, Malta, Spain(L) 
 
Greece, Italy, Malta, Spain 
 Yugoslavia(M)  Bosnia Herzegovina, Croatia, Macedonia, Slovenia, Yugoslavia 
 Portugal(M) Portugal 
Western Europe(M) Austria, Belgium, France, Germany, Luxembourg, The Netherlands, Switzerland 
 Austria(M) Austria, 
 Germany(M) Germany 
 Other Low risk areas(L) Belgium, France, Luxembourg, The Netherlands, Switzerland 
Australia and New Zealand(L) Australia, New Zealand 
Melanesia(H) Fiji, Papua New Guinea, Oceania, Tonga 
(L) Low risk region (<10 ASR); (M) Medium risk region (10-20 ASR); (H) High risk region (>20 ASR) 
 
 
